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1 General introduction 
Colorectal cancer (CRC) is the third most common cancer in men and the second most 
common cancer in women with nearly 1.4 million people diagnosed worldwide in 2012 [1]. 
It is expected that by 2030 the number of worldwide newly diagnosed cases will increase to 
2.2 million annually [2, 3]. At the same time of globally increasing incidences, survival rates 
of CRC patients are rising due to earlier diagnoses and more effective treatment methods, 
leading to a growing group of CRC survivors [2, 4]. Thus, identifying and characterizing 
factors that affect these survivors’ daily life and their survival time is becoming a more 
important global public health interest. 
Lifestyle factors, like dietary behavior and physical activity, are evidentially associated with 
the incidence of a considerable number of different types of cancer [5-9] with CRC being 
one of the most lifestyle-influenced cancers [10, 11]. However, specific and official lifestyle 
recommendations for cancer survivors are still lacking. So far, dietary and physical activity 
recommendations for cancer survivors are the same recommendations as for cancer 
prevention, as released from the World Cancer Research Fund (WCRF)/American Institute 
for Cancer Research (AICR) in 2007 [12, 13]. Furthermore, as survival rates of CRC patients 
are improving and, thus, more people are living a life beyond CRC, health-related quality of 
life (HRQOL) in those CRC survivors is rising to a key issue. 
Some previous studies investigated the associations of selected dietary factors, obtained 
some time after the cancer diagnosis (‘postdiagnostic’) with CRC mortality, including dairy 
products, calcium, vitamin D, sugar-sweetened beverages, red and processed meat, and 
the glycemic index, with the results being rather inconclusive [14-17]. Most of those studies 
investigated single foods, food groups, or nutrients. However, the complexity of diet is likely 
to be better represented by dietary pattern analyses which might also capture synergistic 
and antagonistic nutrient and food interactions [18, 19]. 
Physical activity has been shown to be associated with numerous beneficial health effects 
like reduced body weight and cardiovascular risk, decreased cancer risk, and improved 
survival in the general population and in different patient groups [7, 20-22]. Some prior 
studies examined the association between physical activity and mortality after CRC 
diagnosis and suggested higher amounts of physical activity being related to improved CRC 
survival [23-26]. However, most previous studies assessed physical activity within a 
relatively short time interval after CRC diagnosis. Thus, evidence regarding the association 
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of physical activity with mortality later on after diagnosis is still scarce. Additionally, the 
contribution of different types of activity (e.g., sports, cycling, housework) to the beneficial 
effect of total physical activity on CRC survival has not yet been investigated, so far. 
Besides prolongation of life, improving HRQOL should be a key goal of CRC treatment [27]. 
Studies revealed that the HRQOL status of CRC survivors varies between populations, 
between individuals, and between different HRQOL domains [28-32]. The knowledge of 
factors affecting HRQOL in CRC survivors may facilitate the identification of individuals with 
an especially high risk of a low HRQOL or the adjustment of modifiable risk factors [33]. 
HRQOL of CRC survivors has been associated with mortality in several studies [34-38], but 
these previous studies assessed HRQOL primarily rather shortly after diagnosis or even 
before treatment initiation. Moreover, some studies focused particularly on individuals with 
an advanced (metastatic) cancer stage [37, 39]. Therefore, further studies are needed that 
examine the relation between HRQOL and mortality in CRC survivors in the long term after 
diagnosis. 
The majority of studies that examined lifestyle factors in relation to CRC survival assessed 
diet and physical activity before cancer diagnosis in population-based studies [40]. 
Moreover, even those studies that assessed diet and physical activity after diagnosis are 
often very heterogeneous regarding timing of exposure (diet, physical activity, quality of life 
(QOL)) assessment. However, the survival time from diagnosis until exposure assessment 
might have a considerable effect on the relations between lifestyle factors and HRQOL and 
mortality. For example, studies have reported that many cancer survivors modify their 
dietary and physical activity habits after cancer diagnosis to improve health and prevent 
recurrence [41-45]. Furthermore, dietary behavior and physical activity during or shortly 
after therapy might be affected by adverse treatment effects [46-49]. Therefore, the timing 
of lifestyle factor assessment might play an important role for outcome manifestation and 
the assessment several years after diagnosis and treatment is more likely to reflect the real 
and long-lasting individual dietary and physical activity habits which might have the 
strongest and enduring influence on health and survival. Thus, long-term cancer survivors 
(>5 years survived after diagnosis) may embody a special group of interest in research 
settings. 
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1.1 Public health relevance 
Colorectal cancer 
CRC is a heterogeneous disease characterized by carcinomas in the colon or rectum which 
are both parts of the gastrointestinal (digestive) system [50, 51]. The majority of colorectal 
carcinomas arise slowly from adenomas or adenomatous polyps over years or even a 
decade, involving a series of histological, morphological, and genetic changes [52]. 
Evidentially, the development of CRC is associated with genetic, environmental, and 
lifestyle (e.g., physical inactivity, obesity, diet, smoking) factors [51, 53]. Approximately two-
thirds of CRC patients undergo surgical tumor resection with curative intent [54, 55]. If 
indicated, patients additionally receive neoadjuvant (before surgery) or adjuvant (following 
surgery) therapies, including chemotherapy or radiation therapy, or a combination of both 
[51, 54, 56]. 
CRC is one of the most common malignancies in the Western world. It is the third most 
common cancer in men and the second most common cancer in women, affecting 
approximately 746.000 men and 614.000 women worldwide in 2012 [57]. Thus, CRC 
accounts for about 10% of all cancer cases [57]. In Germany, there were ~61.000 people 
diagnosed with CRC in the year 2014 [58]. Globally, the highest incidence rates are found 
in Japan, North America, Oceania, and Europe. Although current incidence rates are lower 
in developing as compared to developed countries, incidence is constantly rising in several 
developing countries [57, 59]. CRC incidence increases with age. The mean age at 
diagnosis is 75 years for women and 72 years for men in Germany. More than half of 
patients that are diagnosed with CRC are older than 70 years [60], though the incidence of 
CRC in younger individuals is increasing [61, 62]. 
In 2012, there were 694.000 deaths from CRC worldwide (8.5% of all cancer deaths) [57] 
and by 2030 there are 1.1 million deaths predicted [2, 3]. In Germany, CRC accounts for 
approximately 25.000 deaths per year [60]. However, due to substantial improvements in 
cancer detection and treatment strategies, the group of people surviving cancer is growing 
[4]. Death rates of CRC have fallen each year by on average 2% (1997-2007) in Europe 
and 2.5% (2005-2014) in the United States (US) and the 5-year relative survival is about 
65% in the US and about 63% in Germany [58, 63, 64]. 
A ‘cancer survivor’ is defined as any person who has ever been diagnosed with cancer, 
from the time of diagnosis until the end of their life [65, 66]. Cancer survivorship is a 
continuum that comprises phases of treatment and recovery, long-term disease-free living 
or living with stable disease, and, in some cases, living with advanced cancer disease [67]. 
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Each of these phases implies different needs and challenges for survivors [67]. One of these 
challenges is that individuals who have been diagnosed with cancer have an increased risk 
of second primary cancers [68] and are also more likely to develop other chronic diseases 
such as cardiovascular diseases, diabetes mellitus, and pulmonary diseases [69-73]. The 
concept of ‘cancer survivorship’ has its origin in North America [74] and has gained 
importance in Europe relatively recently [75]. With the increasing number of cancer 
survivors, the field of cancer survivorship, examining experiences and outcomes of cancer 
survivors, will continue to gain more attention in research and clinical settings [76]. 
 
Diet and physical activity as lifestyle factors influencing disease risk 
Nutritional factors, dietary behavior, and physical activity are known to exert substantial 
influence on a large number of diseases (e.g., cardiovascular diseases, metabolic 
disorders, and cancer) as well as on physical and mental health conditions [7, 20-22, 77-
82]. During the last decades, large parts of the population were getting less physically 
active, spent more time with sedentary activities (e.g., television (TV) viewing, using the 
computer), and increasingly adhered to a unhealthy diet with a high consumption of fast 
food and fortified foods [83]. Low levels of physical activity and energy-dense, fat-, and 
sugar-rich diets are evidentially related to overweight and obesity, which is an increasing 
public health problem [84]. Besides, suboptimal diet quality and physical inactivity have 
been shown to be among the leading modifiable causes of death and disability in the world 
[85]. As nutrition and physical activity are a natural part of everyone’s daily life, the 
modification of these behavioral factors is conceptually a promising path for disease 
prevention and health promotion. 
Cancer survivors are increasingly interested in lifestyle recommendations to prevent cancer 
recurrence and to improve QOL and survival after diagnosis [12, 67]. Therefore, informed 
lifestyle choices for cancer survivors are becoming particularly important. However, current 
dietary and physical activity guidelines for cancer survivors are the same as for cancer 
prevention in healthy individuals [13]. Major cancer-related research organizations like the 
WCRF are calling for research on lifestyle factors linked to cancer outcomes [86]. Because 
cancer survivors are also at higher risk for other chronic diseases, as for example 
cardiovascular diseases, when compared to the general population [69, 87], understanding 
the role of lifestyle factors for cancer-specific, noncancer, and overall outcomes is of clinical 
and public health relevance [88-90]. 
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In nutritional epidemiology, dietary pattern analyses, instead of analyses of isolated 
nutrients or foods, are gaining importance since dietary patterns are more likely to exert an 
effect on health rather than just single dietary components [18, 19, 91]. One of the most 
established and widely known dietary patterns is the Mediterranean diet. It is characterized 
by high consumption of vegetables, fruits and nuts, legumes, fish, and unprocessed cereals 
and low consumption of dairy products, meat, and poultry. Furthermore, a high ratio of 
monounsaturated lipids to saturated lipids and a moderate alcohol intake (mainly in the form 
of (red) wine) is part of the Mediterranean diet [92, 93]. Besides its lipid-lowering effects 
through a low content of saturated lipids, the Mediterranean diet has been shown to exert 
a broad range of beneficial health effects [79, 82, 94-100]. To assess the degree of 
adherence to the Mediterranean diet, Trichopoulou et al. [92, 101] constructed an a priori, 
hypothesis-based Mediterranean diet scale enabling the application of this scale in 
analytical epidemiologic studies. In the past years, several modified variants of the 
Mediterranean diet scale have been constructed and introduced into research, mainly to 
slightly adjust the instruments to other countries’ dietary behavior (e.g., the US and Non-
Mediterranean Europe), for example by including also polyunsaturated fats in the ratio of 
unsaturated to saturated lipids [94, 102-104]. More recently, a dietary pattern which consists 
of typical healthy Northern European foods has gained attention. The a priori-defined 
‘healthy Nordic Food Index’ has been developed by Olsen et al. [105] and comprises rye 
bread, oatmeal, apple and pears, cabbage, root vegetables, and fish/shellfish. It has been 
investigated in different observational studies that were able to confirm its positive effects 
on various health outcomes, including mortality, cancer, and cardiometabolic disease risk 
[105-109]. 
In the light of decreased physical activity participation and increased sedentary time in many 
populations around the globe, the importance of promoting physical activity as a public 
health intervention is actively being discussed and addressed [110-113]. Most studies 
dealing with physical activity focused on health effects of recreational physical activity. 
However, the impact of occupational physical activity (activities on the way to work or at 
work) and physical activities during the daily routine like, for example, housework, home 
repair, gardening, and stair climbing may as well provide substantial health benefits. The 
latter might be especially important for elderly individuals who retired and rather spend their 
time at home than at work. Additionally, older individuals might be less capable and 
motivated of engaging in high-intensity sports and exercise (e.g., playing soccer or doing 
resistance training) and, therefore, spend more time with light-intensity activities and daily 
routine activities like gardening and housework. Different physical activities are 
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heterogeneous regarding their types and intensities and, potentially, also regarding their 
effects on physical functioning and health [114]. 
 
Health-related quality of life 
Patient-reported outcomes (PROs) are increasingly gaining importance as outcome 
measures in both observational and interventional studies, as well as in clinical practice 
[115-118]. PROs are measurements that are reported by the patients themselves and that 
can represent the patients’ view on the burden of a disease and its treatment [116-118]. 
One of the most widely assessed and applied PROs is HRQOL [116, 118]. Thereby, 
treatment effects are evaluated not only by their influence on quantity of life but also on 
quality of life [118, 119]. QOL is a multidimensional, subjective, dynamic, and person-
centered construct, consisting of physical, functional, emotional, and social dimensions 
[120]. The World Health Organization (WHO) has defined QOL as an ‘Individuals’ 
perception of their position in the context of the culture and value systems in which they 
live, and in relation to their goals, expectations, standards and concerns’ [121]. Symptoms 
play an important role for HRQOL because they have a direct or indirect impact on QOL, 
e.g., by affecting daily activities or family and social life [122, 123]. 
Ideally, cancer survivors recover from disease- or treatment-related acute effects within 
weeks or months after therapy but sometimes side effects of treatment (e.g., fatigue, sleep 
disorders, pain) persist [29, 124-127]. In addition, latent detriments and some treatment 
effects (e.g., second cancers, cardiovascular diseases, osteoporosis) may become 
apparent months or years after treatment completion [126-130]. Thus, CRC survivors can 
be impaired in physical functioning and in everyday life by multiple disease- and treatment-
related symptoms such as pain, fatigue, and bowel dysfunction and may be negatively 
affected in psychological, emotional, social, and role functioning because of fear, anxiety, 
distress, sleep disruption, and depression [123, 131-134]. Some cancer survivors are living 
with a permanent sense of uncertainty and fear of disease recurrence since diagnosis [76]. 
Furthermore, in some CRC survivors, the construction of a stoma might be necessary, 
which can mean both physical as well as psychological impairments [135-139]. Hence, 
international organizations, like the US Institute of Medicine, are highlighting the importance 
of caring for psychosocial needs of cancer survivors [140]. 
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1.2 State of knowledge 
Postdiagnostic diet and colorectal cancer survival 
A few studies have investigated the association between dietary factors and survival after 
CRC diagnosis but most observations were not replicated in other studies [141, 142]. For 
example, high consumption of sugar-sweetened beverages after CRC diagnosis was not 
associated with overall survival in a study of stage III colon cancer patients [17]. However, 
in the same sample, higher dietary glycemic load and higher total carbohydrate intake were 
significantly associated with decreased survival whereas no association was found for 
dietary glycemic index [15]. In another cohort, higher postdiagnostic total fiber and whole 
grain intake were both significantly associated with CRC-specific and all-cause mortality 
[143]. Furthermore, in 953 stage III colon cancer patients, an improvement in survival was 
observed along with increasing coffee consumption, though the association was limited to 
caffeinated coffee [144]. Regarding nutrient intake, postdiagnostic folate and other one-
carbon nutrients showed no association with CRC-specific death [145] and a higher 
postdiagnostic predicted 25-hydroxyvitamin D3 score (including dietary and supplementary 
vitamin D intake) was associated with improved cancer-specific and overall mortality [146] 
while, in another study, the intake of vitamin D showed no association with mortality [14]. 
The postdiagnostic intake of calcium and milk was inversely associated with all-cause 
mortality [14]. In 1925 participants of a randomized trial on adjuvant therapies, the intake of 
total alcohol was not associated with colon cancer outcomes, however, when considering 
different types of alcohol, a higher consumption of red wine was associated with significantly 
better outcomes. Beer and liquor consumption were not associated [147]. Likewise, in 1599 
CRC survivors, an association of postdiagnostic alcohol consumption and mortality could 
not be confirmed [148]. A higher consumption of red and processed meat after CRC 
diagnosis revealed no relation with survival [16] whereas a higher consumption of dark fish 
in colon cancer survivors was associated with improved overall survival [149]. However, the 
intake of marine n-3-polyunsaturated fatty acids was not statistically significantly associated 
with overall survival, but with disease-free survival [149]. 
So far, only few studies have examined dietary patterns in relation to CRC survival. Most 
studies focused on nutrients, foods, and food groups, as presented above. Additionally, 
those studies that investigated dietary patterns in relation to CRC survival were 
inconclusive. One prospective observational study with 1009 stage III colon cancer patients 
reported that a Western dietary pattern, characterized by high intakes of meat, fat, refined 
grains, and desserts, led to significantly decreased survival whereas a prudent pattern, 
characterized by high intakes of fruits and vegetables, poultry, and fish, was not significantly 
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associated with patient outcome [150]. Another study examined the association of five 
different dietary patterns with survival in 1201 women diagnosed with CRC, including the 
Alternate Healthy Eating-Index 2010, the alternate Mediterranean Diet score, the Dietary 
Approaches to Stop Hypertension score, a prudent (healthy), and a Western (unhealthy) 
dietary pattern. From these patterns, only the Alternate Healthy Eating-Index 2010 
displayed a statistically significant inverse association with mortality [103]. 
 
Postdiagnostic physical activity and colorectal cancer survival 
Several systematic reviews and meta-analyses reported significant inverse associations 
between postdiagnostic physical activity and all-cause mortality in CRC survivors [142, 151, 
152]. Specifically, studies examining the impact of physical activity on cancer recurrence 
and cancer survival revealed 25-63% lower all-cause mortality for more active as compared 
to less active patients after CRC diagnosis [23-26, 153-155]. However, these prior studies 
assessed physical activity rather shortly after CRC diagnosis (several months to <5 years 
after diagnosis) and studies examining the effect of physical activity in long-term CRC 
survivors (>5 years after diagnosis) on mortality risk are scarce. Furthermore, evidence on 
the impact of different types of physical activity on survival is missing. In addition to 
frequency and duration of physical activity, also sedentary time, like TV watching hours, are 
of interest with respect to their association with mortality in CRC patients. In this context, 
two studies analyzed the association between postdiagnostic TV viewing and all-cause 
mortality in CRC survivors and observed an increase in mortality with more hours of TV 
watching, though the association failed to reach statistical significance [23, 156]. 
 
Health-related quality of life status and factors associated with health-related quality 
of life in colorectal cancer survivors 
Most previous studies reported generally high HRQOL values in CRC survivors [157-162] 
and improvements in HRQOL over the course of months and years after diagnosis [28]. 
However, on a parallel note, several symptoms and medical issues (e.g., pain, diarrhea, 
fatigue, depressive symptoms, impaired daily functioning) have been reported by CRC 
patients, even years after diagnosis and treatment [30, 32, 158, 159, 161]. 
Different clinical, sociodemographic, and lifestyle factors have been identified to be 
associated with HRQOL in CRC survivors in previous epidemiological studies [28, 34, 163, 
164], even though the results from different studies were partially inconsistent and 
conflicting. As an example, some studies reported higher [28] and some lower [31, 34, 122, 
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165] HRQOL in women as compared to men, whereas other studies observed no significant 
difference between men and women in HRQOL [164]. Older as compared to younger age 
was associated with a lower physical [34, 164] but a higher mental HRQOL [34] and with 
better overall HRQOL [31, 32]. A higher educational level was found to be related to higher 
QOL and higher physical functioning in different cohorts [34, 164, 165]. With respect to the 
association between family status and HRQOL, studies reported inconsistent results [28, 
164-166]. Other studies found a lower social support to be associated with worse HRQOL 
[31, 167, 168]. Lifestyle factors, like higher physical activity [135, 169-171], a more 
beneficial diet [170, 171], nonsmoking [34, 165], and a normal weight or body mass index 
(BMI) [34, 163, 170], were positively associated with HRQOL in previous studies. 
Furthermore, malnutrition was found to be associated with worse QOL scores in 58 CRC 
patients [172]. Regarding tumor location, study results were largely conflicting with either 
no significant association with HRQOL [34], a lower HRQOL for rectal cancer survivors than 
for colon cancer survivors [28] or a lower physical functioning in colon tumor as compared 
to rectum tumor survivors [165]. In terms of treatment modalities, a French study of 207 
rectal cancer survivors reported worse HRQOL in patients who received both chemotherapy 
and radiation as compared to patients receiving only radiation [173]. In a Dutch 
investigation, chemotherapy or radiation alone compared to none was not associated with 
HRQOL [174]. In contrast, two other studies found an increased HRQOL and better physical 
functioning in patients receiving adjuvant treatment as compared to patients not receiving 
adjuvant treatment [28, 175]. Additionally, a more advanced disease stage, more 
comorbidities, and cancer recurrence were associated with worse HRQOL [28, 31, 122, 
164, 165, 176]. Several studies demonstrated that CRC survivors with a stoma had a 
decreased HRQOL, even in the long-term period of two to more than five years 
postdiagnosis [28, 137, 177]. As opposed to this, in one study of 121 rectal cancer patients, 
a stoma construction was found to be associated with a higher global QOL and less 
gastrointestinal problems [178] which was not true for rectal cancer patients in two other 
studies [136, 179]. 
Taken together, HRQOL of CRC survivors has been analyzed in prior studies, but most of 
these studies evaluated rather short-term (≤5 years after diagnosis) treatment- and disease-
related effects on QOL and were mostly based on relatively small sample sizes [30, 165, 
180-182]. 
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Health-related quality of life and colorectal cancer survival 
Lower HRQOL was associated with worse survival in CRC survivors in few prior studies 
[35, 37-39, 165, 180, 181]; some of those have been summarized in a literature review 
[183]. However, these studies mainly assessed HRQOL very shortly after diagnosis and 
therapy or even prior to treatment initiation and some of them assessed HRQOL specifically 
in patients with advanced (metastatic) cancer [37, 39, 181]. So far, only one study assessed 
HRQOL in long-term survivors of CRC and examined its association with mortality. This 
study provided initial evidence for an inverse relation between physical and mental HRQOL 
and mortality risk more than 5 years after diagnosis [34]. 
 
 
1.3 Aims of the present thesis 
The research aims of this doctoral thesis were to investigate whether predefined dietary 
patterns, physical activity, and HRQOL after diagnosis were associated with all-cause 
mortality in long-term survivors of CRC. Further aims were to describe the HRQOL status 
in CRC long-term survivors and to examine correlates of HRQOL in these individuals. 
Specifically, the individual research aims were defined as follows: 
I) To investigate whether the Modified Mediterranean Diet Score and the healthy  
Nordic Food Index, obtained post-diagnostically in long-term survivors of CRC, were 
associated with all-cause mortality in these individuals (Chapter 2). 
 
II) To assess the association of postdiagnostic total physical activity, different types  
of physical activity (‘sports’, ‘cycling’, ‘walking’, ‘gardening’, ‘housework, home  
repair, and stair climbing’), hours of sleeping at night and day, and time spent  
watching TV with all-cause mortality in CRC long-term survivors (Chapter 3). 
 
III) To describe the HRQOL status of CRC long-term survivors (Chapter 4). 
 
IV) To identify sociodemographic and clinical correlates of HRQOL in long-term CRC  
survivors (Chapter 4). 
 
V) To examine the association of HRQOL with all-cause mortality among long-term  
survivors of CRC (Chapter 4). 
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The research goals were addressed by analyzing data of a prospective cohort study initially 
consisting of 2733 CRC survivors who have been recruited by the biobank PopGen 
approximately 4 years after diagnosis [184]. Dietary intake, physical activity, and HRQOL 
were assessed on average (median) 6 years after CRC diagnosis using validated 
questionnaires [185-187]. The ascertainment of vital status was conducted via population 
registries and length of median survival follow-up, beginning at the date of exposure (diet, 
physical activity, and HRQOL) assessment, was 7 years. For details on the study design 
please see also Figure 1 in the appendix. The background, analyses, results, and 
discussion of each aim will be presented in detail in three scientific articles (Chapter 2-4). 
Subsequently, findings will be summarized and discussed in Chapter 5. 
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Supplemental Methods 1 
Clinical and socio-demographic characteristics 
Concerning self-reported clinical factors, information on tumor location, occurrence of 
metastases or other types of cancer (both reported at baseline and follow-up), as well as 
on neoadjuvant and adjuvant cancer therapies were obtained from each participant by 
questionnaires. In a subset of 181 patients, self-reported clinical data on tumor location, 
type of therapy, and metastases were validated against medical records with overall good 
agreement (87 % concordance). Likewise, information on socio-demographic factors were 
obtained from the participants using questionnaires. These questionnaires included 
information on sex, age at diagnosis, age at diet assessment (follow-up), smoking status at 
follow-up, and post-diagnostic body weight and height at baseline and follow-up. Body Mass 
Index (BMI; kg/m²) was defined as weight divided by the square of height in meters. The 
FFQ [1] included additional validated questions concerning physical activity during the past 
12 months [2]. Hours per week spent with different activities (walking, cycling, sports, 
gardening, housework, home repair, stair climbing) were derived from these questions. To 
obtain intensity levels, comparable among each other and to other studies, metabolic 
equivalent of task (MET) values, according to the 2000 Compendium of Physical Activity 
[3], were assigned to each corresponding activity [4].  
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Supplemental Table 2: Sensitivity Analysis (n=1385): Hazard ratios (HR)1 and 95% confidence 
intervals (95% CI) of all-cause mortality according to quartiles of dietary pattern scores after 
excluding individuals who died within 12 months after diet assessment 
 Quartiles 
 Q1 Q2 Q3 Q4 ptrend2 
Modified Mediterranean Diet Score      
Total no. of individuals (deaths), n 378 (27) 311 (22) 313 (23) 383 (28)  
Score, Median (IQR) 3 (2-3) 4 (4-4) 5 (5-5) 6 (6-7)  
Age- & sex-adjusted, HR (95% CI) 1 (Ref.) 0.96 
(0.66-1.41) 
0.90 
(0.61-1.32) 
0.52 
(0.34-0.80) 0.005 
Multivariable-adjusted3, HR (95% CI) 1 (Ref.) 0.98 
(0.67-1.45) 
0.84 
(0.57-1.24) 
0.49 
(0.31-0.76) 0.002 
      
Healthy Nordic Food Index      
Total no. of individuals (deaths), n 233 (17) 577 (42) 291 (21) 284 (21)  
Score, Median (IQR) 1 (1-1) 2 (2-3) 4 (4-4) 5 (5-6)  
Age- & sex-adjusted, HR (95% CI) 1 (Ref.) 0.83 
(0.57-1.21) 
0.76 
(0.48-1.19) 
0.59 
(0.37-0.96) 0.04 
Multivariable-adjusted3, HR (95% CI) 1 (Ref.) 0.87 
(0.59-1.28) 
0.79 
(0.49-1.26) 
0.63 
(0.38-1.05) 0.09 
      
1 Estimated with Cox proportional hazard models 
2 Calculated by modeling the median value of dietary pattern score quartiles as a continuous 
variable 
3 Adjusted for sex, age at diet assessment, BMI, physical activity, survival time from CRC diagnosis 
until diet assessment, tumor location, occurrence of metastases, occurrence of other cancer, 
chemotherapy, smoking status, total energy intake, (time x age), (time x BMI), and (time x 
metastases) 
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Supplemental Table 3: Sensitivity Analysis (n=1166): Hazard ratios (HR)1 and 95% confidence 
intervals (95% CI) of all-cause mortality according to quartiles of dietary pattern scores after excluding 
individuals with known occurrence of metastases 
 Quartiles 
 Q1 Q2 Q3 Q4 ptrend2 
Modified Mediterranean Diet Score      
Total no. of individuals (deaths), n 374 (32) 282 (24) 245 (21) 265 (23)  
Score, Median (IQR) 3 (2-3) 4 (4-4) 5 (5-5) 6 (6-7)  
Age- & sex-adjusted, HR (95% CI) 1 (Ref.) 1.04 
(0.70-1.56) 
0.88 
(0.57-1.36) 
0.60 
(0.36-0.98) 0.04 
Multivariable-adjusted3, HR (95% CI) 1 (Ref.) 1.10 
(0.73-1.66) 
0.88 
(0.56-1.39) 
0.60 
(0.36-0.99) 0.048 
      
Healthy Nordic Food Index     
 
Total no. of individuals (deaths), n 190 (16) 486 (42) 237 (20) 253 (22)  
Score, Median (IQR) 1 (0-1) 2 (2-3) 4 (4-4) 5 (5-6)  
Age- & sex-adjusted, HR (95% CI) 1 (Ref.) 0.94 
(0.61-1.45) 
0.89 
(0.53-1.48) 
0.53 
(0.30-0.94) 0.03 
Multivariable-adjusted3, HR (95% CI) 1 (Ref.) 1.07 
(0.68-1.68) 
1.06 
(0.62-1.82) 
0.65 
(0.36-1.19) 0.18 
      
1 Estimated with Cox proportional hazard models 
2 Calculated by modeling the median value of dietary pattern score quartiles as a continuous variable  
3 Adjusted for sex, age at diet assessment, BMI, physical activity, survival time from CRC diagnosis until 
diet assessment, tumor location, occurrence of other cancer, chemotherapy, smoking status, total 
energy intake, (time x age), and (time x BMI) 
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3 Postdiagnostic physical activity, sleep duration, and TV 
watching and all-cause mortality among long-term 
colorectal cancer survivors: a prospective cohort study 
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3Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, 
Massachusetts, USA  
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Supplemental Table 1 Sensitivity Analysis (n=1357): HRs1 and 95% CIs of all-cause mortality according 
to quartiles of physical activity after excluding individuals who died within 12 months after physical activity 
assessment (n=19) 
 
Total no. of 
individuals 
No. of 
deaths 
Age- & sex-
adjusted HR  
(95% CI) 
Multivariable-
adjusted2 HR  
(95% CI) 
MET-hours/week of total 
physical activity 
   
 
     
Quartile 1 (0-65.2) 339 74 1.00 (Ref.) 1.00 (Ref.) 
Quartile 2 (>65.2-100.7) 339 42 0.65 (0.44-0.95) 0.67 (0.46-0.99) 
Quartile 3 (>100.7-147.0) 340 32 0.52 (0.34-0.79) 0.58 (0.38-0.89) 
Quartile 4 (>147.0) 339 33 0.58 (0.38-0.88) 0.59 (0.39-0.90) 
ptrend3   0.006 0.008 
1 Estimated with Cox proportional hazards models. 
2 Adjusted for sex, age at physical activity assessment, BMI, survival time from CRC diagnosis until physical 
activity assessment, tumor location, occurrence of metastases, occurrence of other cancer, chemotherapy, 
smoking status, alcohol intake, (time x age), (time x BMI), and (time x metastases). 
3 Calculated by modeling the median value of total physical activity quartiles as a continuous variable. 
Abbreviations: BMI, body mass index; CRC, colorectal cancer; Ref., reference. 
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Supplemental Table 2 Sensitivity Analysis (n=1142): HRs1 and 95% CIs of all-cause mortality according 
to quartiles of physical activity after excluding individuals with known occurrence of metastases (n=234) 
 
Total no. of 
individuals 
No. of 
deaths 
Age- & sex-
adjusted HR  
(95% CI) 
Multivariable-
adjusted2 HR  
(95% CI) 
MET-hours/week of total 
physical activity 
   
 
Quartile 1 (0-65.5) 285 58 1.00 (Ref.) 1.00 (Ref.) 
Quartile 2 (>65.5-100.2) 286 35 0.71 (0.46-1.08) 0.72 (0.47-1.11) 
Quartile 3 (>100.2-143.5) 286 25 0.53 (0.33-0.85) 0.60 (0.37-0.97) 
Quartile 4 (>143.5) 285 27 0.66 (0.41-1.05) 0.65 (0.40-1.04) 
ptrend3   0.04 0.05 
1 Estimated with Cox proportional hazards models. 
2 Adjusted for sex, age at physical activity assessment, BMI, survival time from CRC diagnosis until physical 
activity assessment, tumor location, occurrence of other cancer, chemotherapy, smoking status, alcohol 
intake, and (time x age). 
3 Calculated by modeling the median value of total physical activity quartiles as a continuous 
variable. 
Abbreviations: BMI, body mass index; CRC, colorectal cancer; Ref., reference. 
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4 Health-related quality of life in long-term survivors of 
colorectal cancer and its association with all-cause 
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Abstract 
Background: The group of colorectal cancer (CRC) survivors continues to grow worldwide. 
Understanding health-related quality of life (HRQOL) determinants and consequences of 
HRQOL impairments in long-term CRC survivors may help to individualize survivorship care 
plans. We aimed to i) examine the HRQOL status of CRC long-term survivors, ii) identify 
cross-sectional sociodemographic and clinical correlates of HRQOL, and iii) investigate the 
prospective association of HRQOL after CRC diagnosis with all-cause mortality. 
Methods: We assessed HRQOL within a Northern German cohort of 1294 CRC survivors 
at a median of 6 years after CRC diagnosis using the European Organisation for Research 
and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). Cross-
sectional correlates of different HRQOL dimensions were analyzed using multivariable-
adjusted logistic regression models with HRQOL as a binary variable. With multivariable-
adjusted Cox proportional hazards regression models, hazard ratios (HR) of all-cause 
mortality were estimated per 10-point-increments of an HRQOL summary score, a global 
quality of life scale, and HRQOL functioning and symptom domains. 
Results: The median HRQOL summary score was 87 (interquartile range: 75-94). Sex, 
age, education, tumor location, metastases, other cancers, type of therapy, and current 
stoma were identified as correlates of different HRQOL scales. After a median follow-up 
time of 7 years after HRQOL assessment, 175 participants had died. Nearly all HRQOL 
domains, except for cognitive functioning and diarrhea, were significantly associated with 
all-cause mortality. A 10-point-increment in the summary score decreased the risk of death 
by 24% (HR: 0.76; 95% CI: 0.70-0.82).  
Conclusions: HRQOL in CRC survivors appeared to be relatively high in the long term. 
Various clinical and sociodemographic factors were cross-sectionally associated with 
HRQOL in long-term CRC survivors. Lower HRQOL was associated with increased all-
cause mortality. Individualized healthcare programs for CRC survivors (including 
psychosocial screening and interventions) are needed to detect decreased HRQOL and to 
further improve long-term HRQOL and survival.  
 
Keywords: health-related quality of life, long-term survivors, colorectal cancer, correlates, 
mortality 
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Background 
As the group of patients surviving colorectal cancer (CRC) is growing, understanding and 
improving health-related quality of life (HRQOL) in these patients is becoming an important 
field of research [1, 2]. CRC survivors may be impaired in physical functioning and in 
everyday life by multiple disease- and treatment-related symptoms such as pain, bowel 
dysfunction, and fatigue and may be negatively affected in psychological, emotional, social, 
and role functioning because of fear, anxiety, sleep disruption, and depression [3-6]. 
Therefore, reconstitution of physical, social, psychological, and sexual function is pivotal [7]. 
Assessment of HRQOL in CRC survivors provides insight into their experiences of the 
disease, therapy, and recovery, helps to identify risk factors of low HRQOL, and might 
support the choice and design of appropriate interventions and survivorship care plans [8-
10].  
HRQOL in CRC survivors has been addressed in prior studies, but most of these studies 
evaluated rather short-term (≤5 years after diagnosis) treatment- and disease-related 
effects on quality of life (QOL) [11-14]. Long-term HRQOL after CRC diagnosis and, 
especially, its association with survival is not well described. A few studies investigated 
HRQOL in patients who survived at least 5 years after CRC diagnosis but most of them 
relied on relatively small sample sizes. In two studies in the US, a relatively high QOL was 
observed in 227 and 173 CRC survivors, respectively, with QOL obtained ≥5 years after 
CRC diagnosis [1, 15]. Nonetheless, higher prevalence of depression and anxiety in CRC 
survivors as compared to the general population have been reported [1, 10, 16]. With 
respect to factors influencing QOL, different clinical, sociodemographic, and lifestyle factors, 
including age, sex, tumor location, body mass index (BMI), stoma, and physical activity were 
associated with HRQOL of CRC survivors in previous epidemiological studies [8, 17-19], 
though findings were partially inconsistent in terms of their effect sizes and effect directions. 
In a previous investigation, we have examined the relation between selected lifestyle factors 
(diet, BMI, physical activity, and smoking status), modeled as a lifestyle index, and HRQOL 
in our CRC survivor cohort [20] and observed that a favorable diet, more physical activity, 
and lower BMI were significantly associated with higher HRQOL. In the present study, we 
will expand on this previous analysis by i) investigating the association of a broad panel of 
clinical and sociodemographic factors (not considered in our prior analyses [20]) with 
HRQOL and ii) relating HRQOL prospectively to all-cause mortality. To our knowledge, so 
far, only one study examined the association between HRQOL and mortality in long-term 
CRC survivors and provided initial evidence for an inverse relation between physical and 
mental component scores and mortality risk [18]. 
Thus, the aim of this study was three-fold: first, to describe the HRQOL status of a cohort 
of CRC long-term survivors; second, to identify sociodemographic and clinical correlates of 
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HRQOL in these CRC survivors; third, to investigate the association of HRQOL with all-
cause mortality in these individuals.  
 
Methods 
Study population 
Between 2004 and 2007, a total of 2733 patients with histologically-proven CRC, diagnosed 
between 1993 and 2005, have been identified through medical records review in 
collaboration with surgical departments of 23 hospitals in Northern Germany and with the 
regional cancer registry. These patients were enrolled in a prospective study, conducted by 
the biobank PopGen, as reported in more detail elsewhere [20-22]. Briefly, at the time of 
inclusion (baseline; 2004-2007), participants were asked to fill in a questionnaire on clinical 
and sociodemographic characteristics and on selected lifestyle factors (e.g. cigarette 
smoking, alcohol consumption). The study protocol was approved by the ethics committee 
of the Medical Faculty of Kiel University and written informed consent was obtained from all 
study participants. 
A first follow-up assessment was conducted from 2009 to 2011, and 2263 participants who 
initially agreed to be re-contacted were asked to fill in another questionnaire about clinical 
and sociodemographic characteristics, as well as standardized and validated 
questionnaires on diet (food frequency questionnaire [23]), physical activity [24], and 
HRQOL [25].  
Of the 2263 participants re-contacted, 354 individuals were deceased and 31 had moved 
with unknown addresses. From 1677 individuals who filled in the HRQOL questionnaire, we 
excluded individuals with incomplete HRQOL data (n=147), individuals with missing 
information on physical activity (n=169), year of diagnosis (n=30), and vital status (n=30), 
those with implausible length of follow-up (n=4), and participants with a diagnosis of small 
intestine cancer instead of CRC (n=3), leaving an analytical sample of 1294 participants. 
 
Health-related quality of life assessment 
For the assessment of HRQOL (conducted at first follow-up), the German version of the 
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire 
Core 30 (EORTC QLQ-C30; version 3.0) [25] was used. The 30-item self-report 
questionnaire is a validated cancer-specific instrument for the measurement of HRQOL. 
The QLQ-C30 is composed of a global QOL scale and of five multi-item functional scales 
that assess physical, role, emotional, cognitive, and social function. Furthermore, three 
multi-item symptom scales evaluate pain, nausea/vomiting, and fatigue, and six single-item 
scales measure constipation, diarrhea, appetite loss, dyspnea, insomnia, and financial 
difficulties. All items are scored on a scale from 1 (not at all) to 4 (very much), except for 
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global QOL, which is scored from 1 (very poor) to 7 (excellent). A scoring procedure was 
applied according to the EORTC QLQ-C30 Scoring Manual [26]. All scales were linearly 
transformed to standardize the raw scores to scores that range from 0 to 100. High 
functional scores and high global QOL scores indicate high (functional) QOL whereas high 
symptom scores represent more severe symptoms. A summary score was calculated from 
13 scales (excluding global QOL and financial difficulties) with the symptom scales being 
reversed (100 - symptom scale) to obtain a uniform direction of all scales [27], as follows: 
QLQ-C30 summary score = (physical functioning + role functioning + social functioning + 
emotional functioning + cognitive functioning + (100-fatigue) + (100-pain) + (100-
nausea/vomiting) + (100-dyspnea) + (100-insomnia) + (100-appetite loss) + (100-
constipation) + (100-diarrhea)) / 13.  
 
Assessment of sociodemographic, clinical, and lifestyle characteristics 
The self-administered questionnaires on clinical and sociodemographic characteristics 
assessed date of diagnosis, tumor location, neoadjuvant and adjuvant types of therapy, 
occurrence of metastases or other types of cancer, sex, age at diagnosis, age at HRQOL 
assessment (first follow-up), education (≤9, 10, ≥11 years, unknown) and family status 
(single, married, in partnership, divorced, widowed, unknown) at first follow-up, current 
stoma at first follow-up, smoking status at first follow-up, and postdiagnostic body weight 
and height at baseline and first follow-up. BMI (kg/m²) was calculated with weight divided 
by the square of height in meters. We validated self-reported clinical data (tumor location, 
type of therapy, metastases) against medical records in a subset of 181 participants and 
observed overall good agreement (87% concordance). Information on physical activities 
during the past 12 months was obtained with validated questions [24]. Hours per week spent 
with different activities (walking, cycling, sports, gardening, housework, home repair, stair 
climbing) were derived from these questions. To obtain comparable intensity levels, 
metabolic equivalent of task (MET) values, derived from the 2000 Compendium of Physical 
Activity [28], were assigned to each corresponding activity [29].  
 
Vital status ascertainment 
All-cause mortality was first determined in 2014. Participants who did not respond when 
they were re-contacted for an extension of their informed consent, or for whom the spouse 
reported the study participant’s death, vital status was attained from population registries 
and date of death was recorded. In 2016, vital status of all participants was updated via 
population registries and date of death was recorded if participants were deceased. 
Altogether, 175 participants had died since HRQOL assessment.  
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Statistical analyses 
First, medians and interquartile ranges (IQR) were calculated for the summary score, global 
QOL, and for each functioning and symptom scale. For symptom scales, also prevalence 
(defined as a symptom scale >0) were computed.  
Second, in order to determine potential correlates of the different HRQOL scores, odds 
ratios (ORs) and 95% confidence intervals (95% CIs), derived from multivariable-adjusted 
logistic regression models in cross-sectional analyses, were estimated with the respective 
score modeled as a binary outcome (below vs. above the score-specific median) and with 
sociodemographic (sex, age, education, family status) and clinical (tumor location, 
metastases, other cancer, type of therapy, current stoma) characteristics as exposures 
(and, thus, as potential correlates). These models were adjusted for the following variables, 
except the respective exposure variable of interest: sex, age at HRQOL assessment, BMI 
(continuous in kg/m²), physical activity (continuous in MET-hours/week), tumor location 
(colon, rectum both, unknown), occurrence of metastases (yes, no, unknown), occurrence 
of other types of cancer (yes, no, unknown), type of therapy (none, chemotherapy, radiation, 
both, unknown), and current stoma (yes, no, unknown). 
Third, Cox proportional hazards regression models were used to estimate hazard ratios 
(HR) and 95% CIs of all-cause mortality for each 10-point-increment in the summary score, 
in the global QOL score, and in each functioning and symptom scale. The 10-point-
increment was chosen because a 10-point change in QLQ-C30 scales was found to indicate 
a (“subjective significant”) “moderate” change in HRQOL domains [30]. The date of HRQOL 
assessment was the starting point for survival follow-up of this analysis and follow-up ended 
with date of death or date of last vital status assessment whichever came first. We 
conducted a Cox model adjusting for sex and age at HRQOL assessment and a 
multivariable-adjusted model, which was additionally adjusted for BMI, physical activity, 
tumor location, time from diagnosis until HRQOL assessment, type of therapy, occurrence 
of metastases, occurrence of other cancers, current stoma, education (≤9, 10, ≥11 years, 
unknown), family status (single, married/in partnership, divorced, widowed, unknown), and 
smoking status (never, former, current, unknown). We tested the proportional hazards 
assumption by the Schoenfeld residual method and by including time-dependent variables 
in the statistical model. Because age did not meet the proportional hazards assumption, a 
respective time-interaction-term (age x time) was included in each Cox regression model.  
Fourth, to test for nonlinearity in the association of HRQOL with all-cause mortality, a 
restricted cubic spline regression was conducted. For this analysis, the summary score 
(including information from nearly all functioning and symptom scales) was chosen as the 
independent variable. The knots were located on the 5th, 35th, 65th, and 95th percentile [31] 
and the reference value was the median (62.4 score points) of the first quartile of the 
CHAPTER 4  PAPER 3 
 
 
67 
 
summary score. The model was adjusted for the same covariates as the multivariable-
adjusted Cox regression model (mentioned above).  
Fifth, stratified analyses were performed to examine the role of potential effect modifiers 
(sex, age, BMI, education, family status, smoking status, tumor location, therapy, 
metastases, and current stoma) on the association between the summary score and all-
cause mortality. Furthermore, we formally tested for statistical interactions by including 
respective cross product terms (summary score x potential effect modifier) in the statistical 
model predicting all-cause mortality. 
Sixth, to assess the robustness of our results we performed a sensitivity analysis, excluding 
all individuals who reported a diagnosis of metastases or other cancers because 
metastases and additional cancer diseases could influence HRQOL as well as survival. We 
also considered excluding all participants who died within 12 months of HRQOL 
assessment in a second sensitivity analysis but there was no individual who deceased 
within the first 12 months of follow-up.  
 
Results 
Participant characteristics 
The characteristics of the study participants as a total sample and according to an HRQOL 
summary score below or at/above the median are presented in Table 1. Of the 1294 
individuals, 43% were women and the median age at diagnosis was 62 years. HRQOL was 
assessed on average 6 years (median) after CRC diagnosis. Nearly half of the population 
(46%) reported a low educational status and 77% were married or in a partnership at time 
of HRQOL assessment. Sixteen percent of the individuals had a diagnosis of metastases, 
21% reported a diagnosis of another cancer, and half of the participants (53%) had no 
additional cancer therapy except for surgery. A current stoma at time of HRQOL 
assessment was reported by 12% of the CRC survivor cohort.  
 
Health-related quality of life status in long-term colorectal cancer survivors 
The HRQOL summary score had a median of 87.3 (IQR: 75.3-94.4) (Table 2). The global 
QOL scored lower with a median of 75.0 (58.3-83.3). The highest scores of the five 
functional scales were observed for role (100 (66.7-100)) and social (100 (66.7-100)) 
functioning with the highest possible score as the median. Physical, emotional, and 
cognitive functioning were a little bit lower but roughly at a comparable level (between 83.3 
and 86.7; Table 2). Of the nine symptom scales, fatigue and insomnia revealed the highest 
median scores (22.2 (0-33.3) and 33.3 (0-33.3), respectively) and also the highest symptom 
prevalence (70% and 52%, respectively), indicating a higher burden of these symptoms in 
the present cohort. Each of the other symptom scales had a median of 0, indicating on 
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average no or minor symptom burden. Nevertheless, more than one-third of the study 
participants reported any symptoms of pain (44%), dyspnea (38%), and diarrhea (36%), 
respectively (Table 2).  
 
Correlates of health-related quality of life 
Relevant correlates for low values (below the score-specific median) of the different HRQOL 
scales are provided in Table 3. In general, older age (except for emotional and social 
functioning), lower education, tumor location in both the colon and the rectum, metastases 
or other cancers, a combination of chemotherapy and radiation therapy, and a current 
stoma were statistically significant correlates of low HRQOL in cross-sectional analyses 
(Table 3).  
Specifically, women had a statistically significantly higher risk of low physical functioning 
than men but a lower risk of low social and cognitive functioning as compared with men. 
With respect to age, younger survivors (<60 years) had higher odds and older survivors 
(≥80 years) had lower odds for low social functioning as compared to survivors aged 60-69 
years. A high educational level was significantly associated with decreased risk of low global 
QOL and low physical functioning. Rectal tumor survivors were more likely to have a low 
physical and social functioning than colon tumor survivors. Individuals with a diagnosis in 
both locations had nearly two times the odds of a low summary score. Metastases had a 
negative impact on the HRQOL summary score and on social functioning whereas a history 
of other types of cancer affected the HRQOL summary score and global QOL, as well as 
role, social, and cognitive functioning. The combination of chemotherapy and radiation was 
associated with a low HRQOL summary score, low global QOL, and low role und social 
functioning. Individuals with a current stoma at time of HRQOL assessment were more likely 
to have a low physical, role, emotional, and social functioning, as shown in Table 3.  
 
Association between health-related quality of life and all-cause mortality 
After a median follow-up time of 7 years after HRQOL assessment, 175 (13.5%) of the 1294 
participants had died. Higher scores of the HRQOL summary score and of the global QOL 
score were associated with improved survival (HR: 0.76; 95% CI: 0.70-0.82 and HR: 0.80; 
95% CI: 0.75-0.86 for all-cause mortality per 10-point-increment, respectively) (Table 4). 
Restricted cubic spline regression revealed a linear association between the HRQOL 
summary score and all-cause mortality (p<0.0001 for overall association; p=0.87 for 
nonlinearity; Figure 1).  
Furthermore, every functioning scale was statistically significantly inversely related to all-
cause mortality, except for cognitive functioning which was borderline non-significant (HR: 
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0.95; 95% CI: 0.88-1.02), with physical functioning displaying the strongest association (HR: 
0.80; 95% CI: 0.75-0.86; Table 4).  
Each of the symptom scales, except for diarrhea (HR: 1.03; 95% CI: 0.97-1.09), was 
statistically significantly positively associated with all-cause mortality, with financial 
difficulties displaying the weakest (HR: 1.07; 95% CI: 1.01-1.13) and nausea and vomiting 
(HR: 1.31; 95% CI: 1.19-1.43), fatigue (HR: 1.20; 95% CI: 1.13-1.26), and appetite loss (HR: 
1.18; 95% CI: 1.10-1.25) displaying the strongest associations after multivariable 
adjustment (Table 4).  
The stratification by potential effect modifiers revealed a stronger association between the 
HRQOL summary score and survival for individuals who had no therapy in addition to 
surgery as compared to individuals who had either chemotherapy or radiation or both 
chemotherapy and radiation (pinteraction=0.02). Furthermore, participants with a high 
educational status showed a stronger association between HRQOL and all-cause mortality 
than participants with a low or middle educational status (pinteraction=0.03). The association 
was also stronger in individuals with a current stoma than in those without a stoma although 
the interaction term was not statistically significant (pinteraction=0.08; Table 5). 
In a sensitivity analysis, after excluding participants who reported a diagnosis of metastases 
or a diagnosis of other cancers (n=414), the results remained largely unchanged (data not 
shown).  
 
Discussion 
In the present analyses, we describe in detail the HRQOL in long-term survivors of CRC, 
assess cross-sectional correlates of this HRQOL (and its different scales), and evaluate the 
prospective association of HRQOL with all-cause mortality in these CRC survivors. Our 
main observations were as follows: First, in general, the overall HRQOL, obtained 
approximately 6 years after the cancer diagnosis, seems to be relatively high. Role and 
social functioning reached the highest median scores out of the five functioning scales, 
while out of the nine symptom scales, fatigue and insomnia had the highest median scores, 
indicating the highest extent of these symptoms as compared to the other symptoms. 
Second, sex, age, education, tumor location, metastases, other cancers, type of therapy, 
and current stoma were statistically significant correlates of different HRQOL scales. Third, 
the summary score and the global QOL as well as nearly all functioning and symptom scales 
were statistically significantly associated with all-cause mortality in the sense that higher 
HRQOL and better functioning were associated with better overall survival and more 
symptoms were related to worse overall survival. Fourth, the inverse association between 
the HRQOL summary score and all-cause mortality was stronger in individuals who had no 
neoadjuvant or adjuvant therapy as compared to individuals with chemotherapy or both 
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chemotherapy and radiation and stronger in individuals with a high educational status than 
in individuals with a low or middle educational status.      
 
Health-related quality of life status 
Compared to our study, previous studies reported similar high HRQOL values in CRC 
survivors, which are considered to be an indication of overall good QOL [1, 15, 32, 33]. 
However, the HRQOL of our CRC survivor cohort is in several aspects (especially regarding 
emotional, cognitive, and physical functioning) still slightly lower when compared to 
European general (healthy) population samples, though the HRQOL values of elderly 
general population groups (age categories >60 years) approximate those of our CRC 
survivors [34]. Thus, it is conceivable that, on average, CRC survivors in the long term are 
able to gain HRQOL levels comparable to individuals from the general population with about 
the same age. 
 
Association of sociodemographic characteristics with health-related quality of life in cross-
sectional analyses  
In our study, women had a higher risk of a low physical functioning than men but a lower 
risk of a low social and cognitive functioning as compared with men. In contrast to our 
observations, however, a recent US study including 593 CRC survivors reported no 
significant difference between men and women in physical HRQOL and female gender was 
associated with increased risk of a low mental HRQOL [8].  
Similar to our findings, the above mentioned US study reported a tendency towards a lower 
physical HRQOL and higher mental HRQOL in the elderly as compared to younger 
individuals, even though the association between age and HRQOL lost statistical 
significance after multivariable adjustment [8]. However, in a study of the Seattle Colorectal 
Cancer Family Registry, the association between older age and a higher risk of a very low 
physical component summary score remained statistically significant even after 
multivariable adjustment [18]. One possible explanation for the association of older age with 
low physical functioning is the higher prevalence of frailty and multiple comorbidities in the 
elderly [35] which might lead to worse physical functioning and decreased overall HRQOL. 
Similarly, lower cognitive functioning might, as well, rather be a consequence of advanced 
age than of cancer history [36].  
In our study, a higher educational level was associated with higher global QOL and higher 
physical functioning which is in accordance with the above mentioned study on 593 long-
term CRC survivors [8]. However, we did not assess income level which is likely to be highly 
correlated with educational level and which was associated with physical, social, and 
emotional well-being in other studies [10, 37].  
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With respect to the association between family status and HRQOL, the published literature 
is partially conflicting. Whereas in our cohort, family status displayed no evidence for an 
association with HRQOL, other studies reported being single, divorced or widowed or being 
married or in partnership to be inconsistently associated with low or high HRQOL [8, 38]. 
 
Association of clinical characteristics with health-related quality of life in cross-sectional 
analyses  
Regarding tumor location, other studies found either no significant association with HRQOL 
[18] or a lower HRQOL for rectal cancer survivors than for colon cancer survivors [17], which 
is in line with the observations from our analyses. This association might be explained by 
differences in symptoms, treatment modalities, and therapy duration between colon and 
rectum cancer affecting HRQOL [39].  
Comparable to our results, a French study of 207 rectal cancer survivors reported worse 
role and social functioning and lower global QOL scales of the EORTC QLQ-C30 in patients 
who received both chemotherapy and radiation as compared to patients receiving only 
radiation [40]. Additionally, chemotherapy or radiation alone compared to none was not 
associated with HRQOL in our cohort which is in line with findings from a Dutch investigation 
in the PROFILES registry [41]. A combined therapy of radiation and chemotherapy is likely 
to be indicative of a worse disease status and it might be associated with more treatment 
side-effects which would explain the decreased HRQOL [42].  
Several other studies demonstrated that CRC survivors with a stoma had a decreased 
HRQOL, even in the long-term period of two to more than five years postdiagnosis [17, 43, 
44]. In our analyses, one of the strongest negatively influenced HRQOL component by the 
presence of a stoma was the social functioning, as similar reported by a systematic review 
including 10 studies [16]. Stoma patients often are affected by fear, worry, dissatisfaction, 
and embarrassment especially when dealing with it in public areas and social relations [45]. 
  
Of note, the ability to compare results across studies has been limited by the huge variety 
of applied HRQOL assessment instruments (e.g. EORTC-QLQ C30, FACT-C, SF36, SF12). 
Overall, our observations suggest that a more severe disease stage (e.g. tumor located on 
both sides, diagnosis of metastases and other cancers, chemotherapy and radiation, 
current stoma) is associated with lower HRQOL. 
 
Prospective association of health-related quality of life with all-cause mortality  
In our sample, a higher HRQOL was associated with a lower risk of dying which is in line 
with prior studies, although these studies mainly assessed HRQOL in patients with 
advanced disease stages [46]. Consistently, in our study, higher values in the different 
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functioning scales and lower values in the symptom scales were associated with longer 
survival. In agreement with these observations, a very low physical component score (<10th 
percentile) was associated with a higher risk of mortality in 1021 long-term CRC survivors 
of the Seattle Colorectal Cancer Family Registry (HRQOL approximately 5.5 years 
postdiagnosis; HR: 3.97; 95% CI: 2.95-5.34) [18].  
A few studies used the same HRQOL assessment instrument as we did (EORTC QLQ-
C30) and reported likewise significant associations with survival, but those studies 
assessed HRQOL of CRC patients very shortly after diagnosis and therapy (≤1 year) or 
even prior to cancer treatment [11, 47-51]; and some of these studies focused on advanced 
CRC [49, 50]. We expand those results by examining HRQOL in a relatively large sample 
(n=1294) of long-term CRC survivors.  
The underlying mechanisms of the association between HRQOL and survival in cancer 
patients are not yet entirely clear. It is conceivable that individuals with a worse HRQOL 
have more severe CRC or more comorbid conditions. We adjusted our analyses for the 
prevalence of metastases and other cancers as well as for type of therapy, but we could 
not control for tumor stage, recurrence, and comorbidities because of lack of information 
regarding these clinical characteristics. Another potential explanation for the observed 
association between HRQOL and survival might be psychological distress. It has been 
reported that individuals with psychological distress rate their HRQOL lower and that 
psychological distress is associated with increased cancer mortality [52, 53] and increased 
all-cause mortality in the general population [54]. Psychological stress and depression might 
adversely affect cardiovascular physiology [55] and could lead to increased inflammatory 
responses and cortisol release by dysregulating the hypothalamic-pituitary-adrenal axis 
[56].  
Out of the five functioning scales, we observed the strongest association with all-cause 
mortality for physical functioning (HR: 0.80; 95% CI: 0.75-0.86) which might be due to the 
fact that physical functioning is the most affected by bodily health and fitness which is 
related to morbidity and mortality [57]. The strong associations between nausea/vomiting 
and appetite loss and survival could be due to malnutrition, cachexia, or weight loss leading 
to increased morbidity and mortality [58-60]. Furthermore, fatigue which was also 
significantly associated with mortality in our cohort has been shown to be associated with 
mortality even in the general population [61].  
 
Strengths and limitations 
Strengths of our study include the large sample size, the prospective design regarding 
survival analyses with a long follow-up period (median, 7 years), and the validated 
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ascertainment of vital status. Furthermore, HRQOL was assessed with one of the most 
widely used cancer-specific instruments (EORTC QLQ-C30). 
However, there are some limitations that should be noted. Our analyses on correlates of 
HRQOL were cross-sectional, precluding causal inferences. Furthermore, we did not have 
information on comorbidities although it is likely that HRQOL as well as survival are affected 
by certain comorbidities. Additionally, we only had information available on all-cause 
mortality, but not on disease-specific mortality. Also, information on tumor stage was not 
available in our cohort. We only had information on metastases and other cancers. 
Interestingly, a recent review reported inconclusive results regarding the association 
between tumor stage and HRQOL [62]. Furthermore, HRQOL was assessed only once in 
our cohort, so that we were not able to analyze changes of HRQOL over time. The data on 
clinical and lifestyle factors were based on self-report, which is why we cannot completely 
exclude the possibility of recall bias. However, the validation of self-reported clinical data 
against medical records in a subset of 181 patients revealed a concordance of about 87%.  
 
Conclusions 
The HRQOL in CRC survivors seems to be relatively high in the long term. Sex, age, 
education, tumor location, metastases, other cancers, type of therapy, and current stoma 
were associated with overall HRQOL (summary score and global QOL) and with different 
HRQOL scales. Furthermore, lower HRQOL was associated with increased all-cause 
mortality among CRC long-term survivors. Therefore, it is important to monitor HRQOL in 
long-term CRC survivors, particularly since various intervention programs, like physical 
activity interventions, educational programs, and psychotherapeutic interventions, might be 
helpful to further improve HRQOL [10]. Identifying risk factors for HRQOL deterioration may 
enable a better individualized care of CRC survivors. Thus, randomized controlled trials are 
needed to bring light into the causal relationship of clinical and sociodemographic, as well 
as lifestyle, determinants with HRQOL. Special support may be needed for individuals who 
have multiple risk factors for poor HRQOL.  
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Table 1 Characteristics of the total sample of 1294 CRC long-term survivors and according to an HRQOL 
summary score below or at/above the median 
Participant characteristics Total sample 
Summary score  
< median 
Summary score  
≥ median 
Total no. of individuals, n 1294 647 647 
No. of deaths, n (%) 175 (14) 117 (18) 58 (9) 
Sex, n (%)    
Men 740 (57) 362 (56) 378 (58) 
Women 554 (43) 285 (44) 269 (42) 
Age at diagnosis, y 62 (56-66) 62 (56-66) 61 (57-65) 
Age at HRQOL assessment, y 69 (64-73) 69 (63-74) 69 (64-73) 
Time between CRC diagnosis and 
HRQOL assessment, y 6 (5-8) 
 
6 (5-8) 
 
6 (5-8) 
BMI, kg/m² 26.2 (23.9-29.2) 26.4 (24.0-29.4) 26.0 (23.7-28.9) 
Physical activity, MET-
hours/week 
 
101 (65-149) 
 
102 (64-144) 
 
100 (66-152) 
Education, n (%)    
Low 597 (46) 311 (48) 286 (44) 
Middle 393 (30) 196 (30) 197 (30) 
High 292 (23) 135 (21) 157 (24) 
Unknown 12 (1) 5 (1) 7 (1) 
Family status, n (%)    
Single 52 (4) 27 (4) 25 (4) 
Married or in a partnership 991 (77) 482 (75) 509 (79) 
Divorced 65 (5) 37 (6) 28 (4) 
Widowed 147 (11) 76 (12) 71 (11) 
Unknown 39 (3) 25 (4) 14 (2) 
Smoking status, n (%)    
Never 509 (39) 238 (37) 271 (42) 
Former 649 (50) 342 (53) 307 (47) 
Current 116 (9) 56 (9) 60 (9) 
Unknown 20 (2) 11 (2) 9 (1) 
Tumor location, n (%)    
Colon 613 (47) 278 (43) 335 (52) 
Rectum 552 (43) 293 (45) 259 (40) 
Both 58 (4) 39 (6) 19 (3) 
Unknown 71 (5) 37 (6) 34 (5) 
Metastases, n (%)    
Yes 209 (16) 124 (19) 85 (13) 
No 872 (67) 429 (66) 443 (68) 
Unknown 213 (16) 94 (15) 119 (18) 
Other Cancer, n (%)    
Yes 270 (21) 154 (24) 116 (18) 
No 997 (77) 482 (75) 515 (80) 
Unknown 27 (2) 11 (2) 16 (2) 
Therapy, n (%)    
None 681 (53) 319 (49) 362 (56) 
Chemotherapy 285 (22) 135 (21) 150 (23) 
Radiation 40 (3) 21 (3) 19 (3) 
Chemotherapy and radiation 268 (21) 164 (25) 104 (16) 
Unknown 20 (2) 8 (1) 12 (2) 
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Table 1 (continued) 
Participant characteristics Total sample 
Summary score  
< median 
Summary score  
≥ median 
Current Stoma, n (%)    
Yes 151 (12) 89 (14) 62 (10) 
No 1130 (87) 551 (85) 579 (89) 
Unknown 13 (1) 7 (1) 6 (1) 
    
Values are n (%) or median (interquartile range). 
Abbreviations: BMI, body mass index; CRC, colorectal cancer; HRQOL, health-related quality of life; 
MET, metabolic equivalent of task. 
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Table 2 Median and IQR for the HRQOL summary score and its scales and 
symptom prevalence (defined as percent of individuals with any symptoms of 
the respective scale) among 1294 CRC long-term survivors 
QLQ-C30 Scales Median (IQR) 
Symptom 
prevalence 
Summary score 87.3 (75.3 - 94.4)  
Global QOL 75.0 (58.3 - 83.3)  
Functioning scales   
Physical functioning 86.7 (73.3 – 100)  
Role functioning 100 (66.7 – 100)  
Emotional functioning 83.3 (66.7 – 100)  
Cognitive functioning 83.3 (66.7 – 100)  
Social functioning 100 (66.7 – 100)  
Symptom scales   
Fatigue 22.2 (0 - 33.3) 70 % 
Nausea and vomiting 0 (0 – 0) 12 % 
Pain 0 (0 - 33.3) 44 % 
Dyspnea 0 (0 - 33.3) 38 % 
Insomnia 33.3 (0 - 33.3) 52 % 
Appetite loss 0 (0 – 0) 14 % 
Constipation 0 (0 – 0) 24 % 
Diarrhea 0 (0 - 33.3) 36 % 
Financial difficulties 0 (0 – 0) 23 % 
Abbreviations: CRC, colorectal cancer; HRQOL, health-related quality of life; 
IQR, interquartile range; QLQ-C30, Quality of Life Questionnaire Core 30; QOL, 
quality of life. 
CHAPTER 4  PAPER 3 
 
 
83 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T
a
b
le
 3
 O
R
s
a
 a
n
d
 9
5
%
 C
Is
 f
o
r 
lo
w
 (
d
e
fi
n
e
d
 a
s
 v
a
lu
e
s
 b
e
lo
w
 t
h
e
 s
c
a
le
-s
p
e
c
if
ic
 m
e
d
ia
n
) 
H
R
Q
O
L
 s
c
a
le
s
 a
c
c
o
rd
in
g
 t
o
 s
o
c
io
d
e
m
o
g
ra
p
h
ic
 a
n
d
 c
lin
ic
a
l 
c
h
a
ra
c
te
ri
s
ti
c
s
 i
n
 C
R
C
 s
u
rv
iv
o
rs
 (
n
=
1
2
9
4
) 
fr
o
m
 c
ro
s
s
-s
e
c
ti
o
n
a
l 
a
n
a
ly
s
e
s
  
 
n
 
S
u
m
m
a
ry
 
s
c
o
re
 
<
m
e
d
ia
n
 
G
lo
b
a
l 
Q
O
L
 
<
m
e
d
ia
n
 
P
h
y
s
ic
a
l 
fu
n
c
ti
o
n
in
g
 
s
c
a
le
 
<
m
e
d
ia
n
 
R
o
le
 
fu
n
c
ti
o
n
in
g
 
s
c
a
le
 
<
m
e
d
ia
n
 
E
m
o
ti
o
n
a
l 
fu
n
c
ti
o
n
in
g
 
s
c
a
le
 
<
m
e
d
ia
n
 
S
o
c
ia
l 
fu
n
c
ti
o
n
in
g
 
s
c
a
le
 
<
m
e
d
ia
n
 
C
o
g
n
it
iv
e
 
fu
n
c
ti
o
n
in
g
 
s
c
a
le
 
<
m
e
d
ia
n
 
C
h
a
ra
c
te
ri
s
ti
c
s
 
 
O
R
 (
9
5
%
 C
I)
b
 
O
R
 (
9
5
%
 C
I)
b
 
O
R
 (
9
5
%
 C
I)
b
 
O
R
 (
9
5
%
 C
I)
b
 
O
R
 (
9
5
%
 C
I)
b
 
O
R
 (
9
5
%
 C
I)
b
 
O
R
 (
9
5
%
 C
I)
b
 
S
e
x
 
 
 
 
 
 
 
 
 
M
a
le
 
7
4
0
 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
F
e
m
a
le
 
5
5
4
 
1
.1
9
 (
0
.9
4
-1
.5
1
) 
0
.9
5
 (
0
.7
5
-1
.2
1
) 
1
.6
5
 (
1
.2
9
-2
.1
1
) 
0
.9
6
 (
0
.7
5
-1
.2
2
) 
1
.0
1
 (
0
.8
0
-1
.2
7
) 
0
.6
1
 (
0
.4
8
-0
.7
8
) 
0
.7
8
 (
0
.6
2
-0
.9
9
) 
A
g
e
, 
y
e
a
rs
 
 
 
 
 
 
 
 
 
<
 6
0
 
1
9
2
 
1
.3
1
 (
0
.9
3
-1
.8
6
) 
1
.2
1
 (
0
.8
5
-1
.7
1
) 
0
.8
5
 (
0
.6
0
-1
.2
1
) 
1
.2
1
 (
0
.8
5
-1
.7
2
) 
1
.3
8
 (
0
.9
8
-1
.9
6
) 
1
.4
6
 (
1
.0
2
-2
.1
0
) 
1
.1
9
 (
0
.8
5
-1
.6
8
) 
6
0
-6
9
 
5
2
0
 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
7
0
-7
9
 
4
7
9
 
1
.2
1
 (
0
.9
4
-1
.5
7
) 
1
.2
0
 (
0
.9
3
-1
.5
6
) 
1
.7
0
 (
1
.3
1
-2
.2
2
) 
1
.1
5
 (
0
.8
9
-1
.4
9
) 
0
.9
7
 (
0
.7
5
-1
.2
5
) 
0
.7
7
 (
0
.5
9
-1
.0
1
) 
1
.2
9
 (
1
.0
0
-1
.6
6
) 
≥
 8
0
 
1
0
3
 
1
.5
8
 (
1
.0
0
-2
.4
9
) 
1
.8
5
 (
1
.1
5
-2
.9
6
) 
3
.9
1
 (
2
.3
4
-6
.5
2
) 
2
.0
7
 (
1
.3
0
-3
.2
9
) 
0
.8
9
 (
0
.5
7
-1
.3
9
) 
0
.5
8
 (
0
.3
6
-0
.9
4
) 
1
.8
5
 (
1
.1
7
-2
.9
1
) 
E
d
u
c
a
ti
o
n
 
 
 
 
 
 
 
 
 
L
o
w
  
5
9
7
 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
M
id
d
le
 
3
9
3
 
0
.9
9
 (
0
.7
6
-1
.3
0
) 
0
.6
8
 (
0
.5
2
-0
.8
9
) 
0
.9
6
 (
0
.7
3
-1
.2
6
) 
0
.9
5
 (
0
.7
3
-1
.2
5
) 
0
.9
5
 (
0
.7
3
-1
.2
3
) 
1
.0
9
 (
0
.8
2
-1
.4
3
) 
1
.0
4
 (
0
.8
0
-1
.3
5
) 
H
ig
h
 
2
9
2
 
0
.8
6
 (
0
.6
4
-1
.1
6
) 
0
.5
8
 (
0
.4
3
-0
.7
8
) 
0
.6
7
 (
0
.4
9
-0
.9
1
) 
0
.8
7
 (
0
.6
4
-1
.1
7
) 
0
.8
9
 (
0
.6
6
-1
.1
9
) 
0
.7
5
 (
0
.5
5
-1
.0
2
) 
0
.7
9
 (
0
.5
9
-1
.0
6
) 
 
CHAPTER 4  PAPER 3 
 
 
84 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T
a
b
le
 3
 (
c
o
n
ti
n
u
e
d
) 
 
n
 
S
u
m
m
a
ry
 
s
c
o
re
 
<
m
e
d
ia
n
 
G
lo
b
a
l 
Q
O
L
 
<
m
e
d
ia
n
 
P
h
y
s
ic
a
l 
fu
n
c
ti
o
n
in
g
 
s
c
a
le
 
<
m
e
d
ia
n
 
R
o
le
 
fu
n
c
ti
o
n
in
g
 
s
c
a
le
 
<
m
e
d
ia
n
 
E
m
o
ti
o
n
a
l 
fu
n
c
ti
o
n
in
g
 
s
c
a
le
 
<
m
e
d
ia
n
 
S
o
c
ia
l 
fu
n
c
ti
o
n
in
g
 
s
c
a
le
 
<
m
e
d
ia
n
 
C
o
g
n
it
iv
e
 
fu
n
c
ti
o
n
in
g
 
s
c
a
le
 
<
m
e
d
ia
n
 
F
a
m
il
y
 s
ta
tu
s
 
 
 
 
 
 
 
 
 
S
in
g
le
 
5
2
 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
M
a
rr
ie
d
/i
n
 
p
a
rt
n
e
rs
h
ip
 
 
9
9
1
 
 
0
.9
6
 (
0
.5
4
-1
.7
2
) 
 
0
.8
7
 (
0
.4
9
-1
.5
7
) 
 
0
.7
3
 (
0
.4
0
-1
.3
4
) 
 
0
.8
6
 (
0
.4
8
-1
.5
4
) 
 
0
.9
8
 (
0
.5
5
-1
.7
4
) 
 
1
.1
4
 (
0
.6
3
-2
.0
9
) 
 
1
.1
6
 (
0
.6
5
-2
.0
7
) 
D
iv
o
rc
e
d
 
6
5
 
1
.3
5
 (
0
.6
3
-2
.8
9
) 
0
.9
8
 (
0
.4
6
-2
.0
9
) 
0
.9
9
 (
0
.4
5
-2
.1
8
) 
0
.9
7
 (
0
.4
5
-1
.0
8
) 
0
.9
7
 (
0
.4
6
-2
.0
5
) 
1
.0
9
 (
0
.4
9
-2
.4
1
) 
1
.2
1
 (
0
.5
7
-2
.5
5
) 
W
id
o
w
e
d
 
1
4
7
 
0
.9
7
 (
0
.5
0
-1
.8
9
) 
1
.1
4
 (
0
.5
8
-2
.2
4
) 
0
.6
7
 (
0
.3
3
-1
.3
7
) 
0
.8
2
 (
0
.4
2
-1
.6
0
) 
0
.9
4
 (
0
.4
9
-1
.8
2
) 
1
.0
2
 (
0
.5
1
-2
.0
6
) 
1
.3
8
 (
0
.7
1
-2
.6
7
) 
T
u
m
o
r 
lo
c
a
ti
o
n
 
 
 
 
 
 
 
 
 
C
o
lo
n
 
6
1
3
 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
R
e
c
tu
m
 
5
5
2
 
1
.1
1
 (
0
.8
4
-1
.4
5
) 
1
.0
2
 (
0
.7
7
-1
.3
3
) 
1
.3
3
 (
1
.0
1
-1
.7
6
) 
1
.2
8
 (
0
.9
8
-1
.6
9
) 
1
.0
3
 (
0
.7
9
-1
.3
5
) 
1
.4
1
 (
1
.0
7
-1
.8
6
) 
0
.9
0
 (
0
.6
8
-1
.1
7
) 
B
o
th
 
5
8
 
1
.9
5
 (
1
.0
8
-3
.5
4
) 
1
.4
8
 (
0
.8
2
-2
.6
8
) 
1
.3
9
 (
0
.7
7
-2
.5
3
) 
1
.2
3
 (
0
.6
9
-2
.1
9
) 
0
.8
3
 (
0
.4
7
-1
.4
5
) 
1
.1
9
 (
0
.6
6
-2
.1
6
) 
1
.1
4
 (
0
.6
5
-2
.0
2
) 
M
e
ta
s
ta
s
e
s
 
 
 
 
 
 
 
 
 
N
o
 
8
7
2
 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
Y
e
s
 
2
0
9
 
1
.4
3
 (
1
.0
2
-2
.0
1
) 
1
.1
1
 (
0
.7
9
-1
.5
5
) 
1
.2
9
 (
0
.9
1
-1
.8
3
) 
1
.0
4
 (
0
.7
4
-1
.4
6
) 
1
.1
4
 (
0
.8
1
-1
.5
9
) 
1
.4
7
 (
1
.0
3
-2
.1
0
) 
1
.3
3
 (
0
.9
5
-1
.8
6
) 
  
CHAPTER 4  PAPER 3 
 
 
85 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T
a
b
le
 3
 (
c
o
n
ti
n
u
e
d
) 
 
n
 
S
u
m
m
a
ry
 
s
c
o
re
 
<
m
e
d
ia
n
 
G
lo
b
a
l 
Q
O
L
 
<
m
e
d
ia
n
 
P
h
y
s
ic
a
l 
fu
n
c
ti
o
n
in
g
 
s
c
a
le
 
<
m
e
d
ia
n
 
R
o
le
 
fu
n
c
ti
o
n
in
g
 
s
c
a
le
 
<
m
e
d
ia
n
 
E
m
o
ti
o
n
a
l 
fu
n
c
ti
o
n
in
g
 
s
c
a
le
 
<
m
e
d
ia
n
 
S
o
c
ia
l 
fu
n
c
ti
o
n
in
g
 
s
c
a
le
 
<
m
e
d
ia
n
 
C
o
g
n
it
iv
e
 
fu
n
c
ti
o
n
in
g
 
s
c
a
le
 
<
m
e
d
ia
n
 
O
th
e
r 
C
a
n
c
e
r 
 
 
 
 
 
 
 
 
N
o
 
9
9
7
 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
Y
e
s
 
2
7
0
 
1
.3
9
 (
1
.0
5
-1
.8
5
) 
1
.3
8
 (
1
.0
3
-1
.8
3
) 
1
.3
2
 (
0
.9
9
-1
.7
7
) 
1
.3
8
 (
1
.0
4
-1
.8
4
) 
1
.0
3
 (
0
.7
8
-1
.3
7
) 
1
.6
0
 (
1
.2
0
-2
.1
5
) 
1
.3
5
 (
1
.0
2
-1
.7
9
) 
T
h
e
ra
p
y
 
 
 
 
 
 
 
 
 
N
o
n
e
 
6
8
1
 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
C
h
e
m
o
th
e
ra
p
y
 
2
8
5
 
0
.9
0
 (
0
.6
6
-1
.2
3
) 
1
.0
3
 (
0
.7
5
-1
.4
0
) 
1
.1
3
 (
0
.8
2
-1
.5
6
) 
1
.0
7
 (
0
.7
8
-1
.4
7
) 
0
.9
0
 (
0
.6
6
-1
.2
3
) 
1
.2
1
 (
0
.8
8
-1
.6
8
) 
0
.9
3
 (
0
.6
8
-1
.2
7
) 
R
a
d
ia
ti
o
n
 
4
0
 
1
.0
2
 (
0
.5
2
-1
.9
9
) 
1
.5
9
 (
0
.7
9
-3
.2
0
) 
0
.8
9
 (
0
.4
4
-1
.8
2
) 
0
.8
9
 (
0
.4
5
-1
.7
6
) 
0
.6
6
 (
0
.3
4
-1
.2
9
) 
1
.7
4
 (
0
.8
7
-3
.5
0
) 
0
.7
5
 (
0
.3
8
-1
.4
6
) 
C
h
e
m
o
th
e
ra
p
y
 +
 
R
a
d
ia
ti
o
n
 
2
6
8
 
1
.5
6
 (
1
.1
1
-2
.1
8
) 
1
.5
7
 (
1
.1
2
-2
.2
0
) 
0
.9
6
 (
0
.6
8
-1
.3
5
) 
1
.6
2
 (
1
.1
6
-2
.2
7
) 
1
.0
4
 (
0
.7
4
-1
.4
5
) 
2
.3
3
 (
1
.6
4
-3
.3
1
) 
1
.3
3
 (
0
.9
6
-1
.8
5
) 
C
u
rr
e
n
t 
s
to
m
a
 
 
 
 
 
 
 
 
 
N
o
 
1
1
3
0
 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
1
 (
R
e
f.
) 
Y
e
s
 
1
5
1
 
1
.1
1
 (
0
.7
6
-1
.6
2
) 
1
.3
0
 (
0
.8
8
-1
.9
2
) 
2
.1
3
 (
1
.4
2
-3
.2
0
) 
1
.8
7
 (
1
.2
7
-2
.7
7
) 
1
.4
6
 (
1
.0
0
-2
.1
4
) 
2
.4
4
 (
1
.6
0
-3
.7
1
) 
1
.0
3
 (
0
.7
1
-1
.5
0
) 
a
 C
a
lc
u
la
te
d
 w
it
h
 a
 m
u
lt
iv
a
ri
a
b
le
-a
d
ju
s
te
d
 l
o
g
is
ti
c
 r
e
g
re
s
s
io
n
 m
o
d
e
l.
 
b
 A
d
ju
s
te
d
 f
o
r 
s
e
x
, 
a
g
e
 a
t 
H
R
Q
O
L
 a
s
s
e
s
s
m
e
n
t,
 B
M
I,
 p
h
y
s
ic
a
l 
a
c
ti
v
it
y
, 
tu
m
o
r 
lo
c
a
ti
o
n
, 
m
e
ta
s
ta
s
e
s
, 
o
th
e
r 
c
a
n
c
e
r,
 t
h
e
ra
p
y
, 
a
n
d
 s
to
m
a
; 
e
x
c
e
p
t 
th
e
 e
x
p
o
s
u
re
 v
a
ri
a
b
le
 
o
f 
in
te
re
s
t.
 
A
b
b
re
v
ia
ti
o
n
s
: 
B
M
I,
 b
o
d
y
 m
a
s
s
 i
n
d
e
x
; 
C
I,
 c
o
n
fi
d
e
n
c
e
 i
n
te
rv
a
l;
 C
R
C
, 
c
o
lo
re
c
ta
l 
c
a
n
c
e
r;
 H
R
Q
O
L
, 
h
e
a
lt
h
-r
e
la
te
d
 q
u
a
lit
y
 o
f 
lif
e
; 
M
E
T
, 
m
e
ta
b
o
lic
 e
q
u
iv
a
le
n
t 
h
o
u
rs
 o
f 
ta
s
k
; 
O
R
, 
o
d
d
s
 r
a
ti
o
; 
Q
O
L
, 
q
u
a
lit
y
 o
f 
lif
e
; 
R
e
f,
 r
e
fe
re
n
c
e
. 
 
CHAPTER 4  PAPER 3 
 
 
86 
 
Table 4 HRsa and 95% CIs of all-cause mortality per 10-point-increments of QLQ-C30 
scales in CRC survivors (n=1294) 
 Age- & sex-
adjusted  
HR (95% CI) 
Multivariable-adjustedb 
HR (95% CI) 
Summary scorec 0.76 (0.70-0.82) 0.76 (0.70-0.82) 
Global QOLc 0.80 (0.75-0.85) 0.80 (0.75-0.86) 
 
Functioning Scalesc 
 
 
Physical Functioning  0.78 (0.74-0.83) 0.80 (0.75-0.86) 
Role Functioning  0.86 (0.82-0.90) 0.87 (0.83-0.91) 
Emotional Functioning  0.89 (0.84-0.94) 0.88 (0.83-0.94) 
Social Functioning  0.86 (0.82-0.90) 0.87 (0.83-0.92) 
Cognitive Functioning  0.94 (0.88-1.01) 0.95 (0.88-1.02) 
 
Symptom Scalesd 
 
 
Pain  1.11 (1.06-1.16) 1.11 (1.05-1.16) 
Nausea/Vomiting  1.32 (1.21-1.44) 1.31 (1.19-1.43) 
Fatigue  1.21 (1.15-1.27) 1.20 (1.13-1.26) 
Insomnia  1.08 (1.03-1.13) 1.08 (1.03-1.13) 
Dyspnea  1.15 (1.10-1.20) 1.13 (1.08-1.19) 
Appetite Loss  1.19 (1.12-1.27) 1.18 (1.10-1.25) 
Constipation  1.08 (1.03-1.14) 1.09 (1.03-1.15) 
Diarrhea  1.02 (0.97-1.08) 1.03 (0.97-1.09) 
Financial Difficulties  1.09 (1.03-1.15) 1.07 (1.01-1.13) 
   
Values were calculated for a 10-point-increment in scales. 
a Calculated with Cox proportional hazards regression model. 
b Adjusted for sex, age at HRQOL assessment, BMI, physical activity, tumor location, 
time from diagnosis until HRQOL assessment, type of therapy, metastases, other 
cancer, current stoma, education, family status, smoking status, and (age x time). 
c Higher scores of the summary score, the global QOL, and the functioning scales 
indicate a higher HRQOL or a higher functioning. 
d Higher scores of the symptom scales indicate a higher extent of symptoms. 
Abbreviations: BMI, body mass index; CI, confidence interval; CRC, colorectal 
cancer; HR, hazard ratio; QLQ-C30, quality of life questionnaire core 30; QOL, 
quality of life. 
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Table 5 HRsa and 95% CIs of all-cause mortality for a 10-point-increment in HRQOL summary score among 
CRC survivors (n=1294); stratified by potential effect modifiers 
Potential effect 
modifiers 
Total no. of 
individuals 
No. of 
death
s 
Age- & sex-
adjusted HR (95% 
CI) 
Multivariable-
adjustedb HR (95% CI) 
pinteractionc 
Sex      
Men 740 126 0.74 (0.68-0.81) 0.74 (0.66-0.82)  
Women 554 49 0.78 (0.69-0.90) 0.75 (0.65-0.87) 0.40 
Age at HRQOL 
assessment, yearsd 
   
 
 
<69 626 50 0.78 (0.67-0.91) 0.87 (0.74-1.03)  
≥69 668 125 0.73 (0.67-0.80) 0.72 (0.65-0.80) 0.75 
BMI, kg/m²      
<25 497 72 0.69 (0.61-0.77) 0.66 (0.58-0.76)  
25-<30 558 75 0.78 (0.69-0.88) 0.82 (0.71-0.94)  
≥30 239 28 0.81 (0.68-0.97) 0.77 (0.61-0.98) 0.19 
Education      
Low 597 96 0.78 (0.71-0.87) 0.79 (0.71-0.88)  
Middle 393 44 0.81 (0.69-0.96) 0.80 (0.66-0.97)  
High 292 34 0.60 (0.50-0.71) 0.57 (0.45-0.71) 0.03 
Family status      
Married/in partnership 991 127 0.76 (0.69-0.84) 0.77 (0.69-0.85)  
Single, divorced or 
widowed 
 
264 
 
43 
 
0.74 (0.63-0.87) 
 
0.75 (0.63-0.89) 
 
0.86 
Smoking status      
Never 509 53 0.80 (0.69-0.93) 0.80 (0.68-0.94)  
Former 649 105 0.74 (0.67-0.82) 0.73 (0.65-0.81)  
Current 116 14 0.78 (0.60-1.03) 0.72 (0.47-1.09) 0.23 
Tumor location      
Colon 613 72 0.76 (0.67-0.87) 0.78 (0.69-0.89)  
Rectum 552 84 0.77 (0.69-0.86) 0.76 (0.67-0.86) 0.15 
Therapy      
None 681 95 0.68 (0.61-0.75) 0.67 (0.59-0.76)  
Chemotherapy or 
radiation 
 
325 
 
47 
 
0.87 (0.75-1.00) 0.86 (0.72-1.03) 
 
Both 268 31 0.80 (0.66-0.96) 0.89 (0.72-1.10) 0.02 
Metastases      
Yes 209 50 0.76 (0.66-0.89) 0.80 (0.68-0.94)  
No 872 95 0.77 (0.69-0.85) 0.76 (0.67-0.85) 0.88 
Current stoma      
Yes 151 30 0.70 (0.58-0.85) 0.57 (0.43-0.76)  
No 1130 145 0.78 (0.71-0.85) 0.79 (0.72-0.86) 0.08 
      
a Calculated with Cox proportional hazards regression model. 
b Adjusted for sex, age at HRQOL assessment, BMI, physical activity, tumor location, time from diagnosis 
until HRQOL assessment, therapy, metastases, other cancer, current stoma, education, family status, 
smoking status, and (age x time); except the stratifying variable.  
c Calculated by including the cross product of the summary score and the respective potential effect modifier 
in the Cox proportional hazards regression model. 
d Cut-point based on median value. 
Abbreviations: BMI, body mass index; CI, confidence interval; CRC, colorectal cancer; HR, hazard ratio; 
HRQOL, health-related quality of life.
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Figure 1 Multivariable-adjusted hazard ratios for all-cause mortality according to the HRQOL summary 
score in CRC survivors (n=1294), calculated with restricted cubic spline regression. The solid line depicts 
hazard ratios and the dashed lines are the 95% CIs. The points indicate the knots at the 5th, 35th, 65th, and 
95th percentiles. The reference value is the median (62.4 score points) of the first quartile of the summary 
score. The model was adjusted for sex, age at HRQOL assessment, BMI, physical activity, survival time 
from CRC diagnosis until HRQOL assessment, tumor location, occurrence of metastases, occurrence of 
other cancer, therapy, education, family status, and smoking status. The p value for overall association is 
<0.0001 and the p value for nonlinearity is 0.87 (Wald chi-square test). Abbreviations: BMI, body mass 
index; CRC, colorectal cancer; HRQOL, health-related quality of life. 
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5 General discussion 
As the group of individuals surviving CRC is constantly growing, lifestyle factors and QOL 
after CRC diagnosis are becoming increasingly important. This doctoral thesis 
systematically assessed the association of specific dietary patterns, physical activity, and 
HRQOL several years after diagnosis with all-cause mortality in CRC long-term survivors. 
Furthermore, the HRQOL status and important clinical and sociodemographic correlates of 
HRQOL in long-term survivors of CRC were evaluated. The results of this thesis were 
presented in three articles. The main observations were as follows: 
I) Stronger adherence to the Modified Mediterranean diet was associated with better 
overall survival, even after accounting for relevant potential clinical and 
sociodemographic confounders. Also, the healthy Nordic Food Index was inversely 
associated with all-cause mortality when modeled as a continuous variable, even 
though quartiles of the healthy Nordic Food Index slightly failed to reveal a statistically 
significant association. 
 
II) More postdiagnostic total physical activity was associated with significantly lower all-
cause mortality as compared to less physical activity. Regarding individual types of 
physical activity, sports, walking, and gardening were particularly strongly inversely 
related to all-cause mortality. A greater amount of sleeping during the day was 
associated with shorter survival, whereas the amount of sleep at night was not 
associated with survival. More hours per day spent watching TV were associated with 
a higher all-cause mortality in this CRC survivor cohort. 
 
III) The HRQOL generally seemed to be relatively high in CRC survivors approximately 
(median) 6 years after diagnosis. On average, the highest functioning was reported for 
role and social functioning. Fatigue and insomnia represented the symptoms with the 
highest extent out of nine symptom scales. 
 
IV) Sex, age, education, tumor location, metastases, other cancers, type of therapy, and a 
current stoma were identified as sociodemographic and clinical correlates of overall 
HRQOL and of different HRQOL scales. 
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V) The summary score and the global QOL as well as nearly all functioning and symptom 
scales were statistically significantly associated with all-cause mortality in the sense that 
higher HRQOL and better functioning were associated with better overall survival and 
more symptoms were related to worse overall survival. Out of the functioning scales, 
physical functioning displayed the strongest positive association with HRQOL whereas 
cognitive functioning was not statistically significantly associated. Of the nine symptom 
scales, diarrhea was not related to all-cause mortality while fatigue, nausea/vomiting, 
and appetite loss revealed the strongest association with survival. 
 
 
 
5.1 Extension of previous knowledge 
In view of the fact that analyses on postdiagnostic dietary factors related to CRC survival 
were largely limited to nutrients, single foods, or food groups, and that dietary pattern 
analyses are scarce, this doctoral thesis adds to the previous knowledge by providing initial 
evidence for a positive association between two established dietary patterns (the 
Mediterranean diet and the healthy Nordic diet) and overall survival in CRC survivors. While 
the healthy Nordic diet has been examined for the first time with respect to its association 
with mortality after CRC diagnosis in this thesis, the Mediterranean diet (adopted for the 
American population) was obtained postdiagnostically and tested in relation to survival 
among CRC patients in one prior analysis [1]. In that study, also an inverse association with 
mortality was observed, but statistical significance could not be reached. However, this 
study assessed diet much earlier after diagnosis (median, 21 months) [1] as compared to 
the study of this thesis (median, 6 years). 
With respect to physical activity, this thesis expands the existing evidence by showing that 
the positive association between physical activity and overall survival, already shown for 
physical activity earlier after diagnosis [2-4], also applies to long-term survivors (≥5 years) 
of CRC. Additionally, this thesis investigated for the first time the association of different 
types of postdiagnostically assessed physical activity with mortality in CRC survivors and 
revealed significant associations with survival primarily for sports, walking, and gardening. 
Furthermore, a higher amount of sedentary time (sleeping at day, watching TV) was 
significantly inversely associated with all-cause mortality. In two prior studies, more hours 
of TV viewing were also related to higher mortality, though not statistically significant [5, 6]. 
The relatively high HRQOL status of the present CRC survivor cohort confirms the findings 
of previously conducted studies [7-12]. The results regarding sociodemographic correlates 
of HRQOL were partially concordant (e.g. for age, education) [13-15] and partially 
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inconsistent (e.g. for sex, family status) [13-18] with prior studies. In terms of clinical 
correlates of HRQOL, for tumor location, differing results were observed in previous studies, 
partly supporting the findings of this thesis [19] and partly disagreeing [14, 15]. Likewise, for 
treatment modalities, some study results were similar [20, 21] to this thesis’ findings 
whereas some studies found different associations [19, 22]. Previously, a more advanced 
disease stage, which likely includes the occurrence of metastases and other cancers, was 
associated with worse HRQOL [15, 17-19]. The majority of studies on stoma construction 
in relation to HRQOL were in accordance with the findings of this doctoral thesis, suggesting 
a lower HRQOL in individuals with a stoma [19, 23, 24]. 
Several studies provided some evidence for an association between a higher HRQOL and 
improved CRC survival as compared to a lower HRQOL, but these studies assessed 
HRQOL primarily rather shortly after CRC diagnosis or even before initiation of cancer 
therapy and some of them focused on patients with advanced cancer stage [15, 25-30]. 
Thus, this thesis extends the previous knowledge by revealing that the association between 
HRQOL and CRC survival is also present in long-term survivors of CRC, which, so far, has 
only been suggested in one prior study [14]. 
 
 
5.2 Implications for public health 
While comprehensive guidelines for clinical practice regarding diagnosis and treatment of 
cancer exist, evidence-based clinical guidelines for posttreatment survivorship care are 
scarce. The increasing number of cancer survivors is challenging oncologists and primary 
care clinicians by demanding specified follow-up care [31, 32]. Physical activity and 
nutritional assessment and intervention are not traditional parts of cancer treatment and 
survivorship programs [33-35]. However, especially in the phase of long-term disease-free 
living or stable disease, an important focus should be on lifestyle goals like weight 
management, a healthy diet, and being physically active [36, 37]. Moreover, the knowledge 
of lifestyle factors after diagnosis that have an influence on cancer survival is particularly 
promising because cancer survivors are theoretically able to actively modify their behavior 
after diagnosis in order to improve cancer outcome, target comorbidities, and enhance 
general health [38-41]. Additionally, cancer survivors wish to have a more active role in their 
health care after diagnosis and are eager to know which lifestyle changes they should carry 
out [36, 42, 43]. 
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Dietary patterns 
This doctoral thesis was able to show that a higher adherence to the Mediterranean diet 
and to the healthy Nordic diet, respectively, were beneficially associated with overall 
survival in CRC long-term survivors. In the last decades, even apart from the Mediterranean 
countries where the Mediterranean diet has its origins, the Mediterranean dietary pattern 
has gained enormous popularity and implementation also in other regions like the US and 
Northern and Western Europe and is recommended by Health Services as a healthy diet 
choice [44, 45]. Besides its effect on cancer incidence and cancer mortality, the 
Mediterranean diet is also associated with a decline in total mortality and cardiovascular 
mortality in the general population [46, 47]. Frequently, nutritional scientists are discussing 
whether the traditional Mediterranean diet is implementable in Non-Mediterranean countries 
[48, 49]. Especially the high amount of monounsaturated fatty acids is suggested to be 
responsible for a large proportion of the health-promoting effect of the Mediterranean diet 
[49] and in Non-Mediterranean countries, the diet usually contains higher amounts of 
polyunsaturated than of monounsaturated lipids [50, 51]. However, alternatively to olive oil 
which is rich in polyunsaturated fatty acids and traditionally used in Mediterranean 
countries, it is also reasonable to advise patients or individuals to use canola oil or canola 
oil-based margarine, which is more common in Western Europe and Northern America, in 
addition to other Mediterranean foods like nuts and fatty fish to reproduce the fatty acid 
profile that is characteristic of the Mediterranean population [52]. Thus, modifications that 
keep the advantageous effects of the traditional dietary pattern are feasible [50]. 
Apart from the Mediterranean diet, evidence on the beneficial impact of the healthy Nordic 
diet indicate that the potential positive aspects of the traditional Nordic diet are not to be 
neglected [53-57]. Hence, the healthy Nordic diet might be a promising dietary pattern for 
health promotion especially for Northern German people, as represented in the cohort of 
this thesis, but as well for other Northern European and Northern American populations 
[53]. The healthy Nordic diet might be easier to implement and may be more sustainable 
because of its stronger familiarity and cultural acceptance in the Northern area as compared 
to the Mediterranean diet [53, 54]. In general, it might be reasonable to promote regional 
diets, like the healthy Nordic diet in Northern Europe, in order to enhance health and 
decrease disease burden, because this approach may increase the people’s compliance 
[58]. 
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Physical activity promotion 
During the last years, evidence has been growing that physical activity is not just beneficial 
in terms of survival, but that it is also safe and well-accepted by cancer patients during and 
after treatment [59, 60]. Additionally, exercise contributes to an increase in quality of life 
and to improvements of physical functioning among cancer survivors [61-65]. Moreover, 
physical activity also reduces cancer-related fatigue [66, 67]. In general, physical activity 
might be an attractive strategy to help preventing cancer recurrence and to prolong life in 
cancer survivors as it is likely to also substantially reduce the risk for many other diseases 
which accumulatively appear in cancer survivors, especially in the elderly, including 
coronary heart disease, stroke, type 2 diabetes, and dementia [68-70]. Furthermore, the 
Physical Exercise Across the Cancer Experience framework [71] suggests that physical 
activity contributes to the attenuation of adverse treatment effects and to coping with 
treatment during the immediate therapeutic phase. 
Thus, the accumulating available evidence of numerous studies indicates that it is 
reasonable to encourage CRC survivors to be regularly physically active and to minimize 
TV viewing time. Some types of physical activity, as for example sports, lower-intensity 
activities like walking, and diverse activities like gardening, might have a stronger inverse 
association with mortality than other activities but more studies are needed to confirm these 
findings. Of note, cancer survivors, especially CRC survivors, are mostly of higher age 
because colon and rectum carcinomas are most frequently diagnosed in persons at the age 
of around 70 years [72, 73]. In this age group, physical activity can induce a lot of 
advantages in health, QOL, and social life but might also represent a practical challenge for 
some individuals due to age-related limitations or comorbidities [74-76]. Therefore, physical 
activity interventions and recommendations should always be individually adapted to every 
person’s preferences and physical abilities.  
 
Lifestyle recommendations and interventions 
The findings of this doctoral thesis, together with those of previous investigations and with 
results of future studies might be helpful to develop evidence-based lifestyle 
recommendations for cancer survivors. Such recommendations for cancer survivors would 
represent an important basis for physicians and other health professionals to guide cancer 
survivors towards optimal lifestyle choices [36]. However, before evidence-based 
recommendations can be issued, interventional studies need to demonstrate in a 
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randomized controlled setting that specific modifications in diet and physical activity indeed 
improve HRQOL and survival in long-term CRC survivors. 
However, it might be necessary to also implement active support (e.g., supervised exercise 
programs, nutrition counseling) for CRC survivors, instead of only publishing 
recommendations, in order to improve lifestyle behavior because initiating and maintaining 
lifestyle changes without support may be a huge barrier to overcome for some affected 
individuals [36, 77]. Studies revealed that only 20-30% of cancer survivors will be physically 
active after recovery from treatment [78]. Furthermore, it might be beneficial to involve 
family members to provide more social support and to assist the cancer survivor in changing 
lifestyle behaviors [77]. CRC survivors also reported the wish to receive information about 
potential lifestyle support early after diagnosis to make autonomous and informed decisions 
during active treatment [77]. Thus, lifestyle recommendations and support should be 
routinely offered by oncology health care professionals to enable CRC survivors improving 
their lifestyle through informed decision making [77]. 
A randomized controlled trial in CRC patients reported that early individualized nutritional 
counseling and education had a long-term effect on cancer outcomes (e.g., survival), as 
well as on sustained nutritional intake, diet behavior, and QOL [79]. A similar randomized 
controlled trial was conducted focusing on physical activity. Patients who received an 
oncologist’s exercise recommendation with an additional exercise motivation package 
significantly increased their level of exercise participation as compared with a group of 
patients only receiving the oncologist’s exercise recommendation without a motivation 
package and compared with a control group without an intervention [80]. 
 
Health-related quality of life surveillance 
Despite the fact that CRC survivors usually report a relatively high HRQOL, there is a wide 
range of factors (clinical, sociodemographic, lifestyle) that can potentially be targeted to 
further improve HRQOL in these individuals, especially in view of the fact that decreased 
HRQOL is associated with worse survival. Assessment of HRQOL in CRC survivors might 
provide insight into the individuals’ experiences of the disease, therapy, and recovery and 
helps to identify risk factors of a low HRQOL [13, 81, 82]. Identifying risk factors for HRQOL 
deterioration may enable a better individualized care of CRC survivors, particularly among 
vulnerable subgroups of survivors. In addition to the assessment of HRQOL in clinical trials, 
the surveillance of HRQOL in clinical practice can reveal important information on disease 
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burden and physical and psychosocial detriments of cancer survivors. Therefore, it is 
important to monitor HRQOL early and regularly over a long period in CRC survivors [82]. 
Additionally, the findings of this doctoral thesis suggest that low levels of HRQOL identify 
CRC survivors with a higher risk of dying. To target physical and psychosocial deteriorations 
and to further improve HRQOL, various intervention programs, like physical activity 
interventions, educational programs, psychosocial interventions, and self-help groups, 
could be helpful and valuable. Educational programs might help to enhance cancer-related 
knowledge and, thus, improve emotional dealing with the disease and its treatment. 
Psychotherapeutic interventions may include support in emotional expression, increasing 
personal resources, improving coping skills, and regaining control in everyday life [82]. 
 
 
5.3 Methodological considerations 
 
5.3.1 Survival analyses 
Survivorship bias 
The analyses of this doctoral thesis might be prone to survivorship bias because individuals 
with a generally higher risk of dying (e.g., with a more advanced cancer stage at diagnosis) 
might not have been included in the analyses as they might have died before exposure 
assessment (median, 6 years after diagnosis). On the one hand, this could lead to an 
overestimation of the benefit from being exposed [83]. On the other hand, it might be 
questionable whether or not the mortality of this CRC survivor cohort is still related to the 
former cancer disease. However, the objective of this thesis was to examine ‘long-term’ 
survival after CRC diagnosis (in relation to lifestyle factors and HRQOL), and in the case of 
mortality of long-term cancer survivors it is less important whether these individuals die from 
cancer than, rather, when they will die (from any cause). Long-term cancer survivors are a 
special group of individuals characterized by their history of a cancer disease that, in the 
majority of cancer survivors, has a significant influence on their physical and psychological 
health for the rest of their lives. 
 
All-cause vs. cause-specific mortality 
Within this thesis, vital status of study participants was ascertained by requesting 
information on current residencies or, if a participant had deceased, date of death at the 
local population registries. Thus, only date of death (mortality from all causes), but no 
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causes of deaths were available for the survival analyses. Therefore, analyses on cause-
specific, for example cancer-specific, mortality could not be conducted. However, since 
long-term cancer survivors have a higher incidence of other chronic disease conditions, 
mostly due to disease- and treatment-related effects, deaths of other causes than cancer-
related ones are of essential importance. Long-term cancer survivors with high cancer-
related survival rates often die of cardiovascular diseases instead of their cancer disease 
[84, 85]. In addition, cancer survivors have a higher risk of non-cancer deaths than age-
standardized general population controls [85, 86]. When examining cancer-related 
mortality, only directly cancer-caused deaths are considered, whereas other deaths that are 
indirectly caused by the cancer (cancer-consequent; e.g., cardiovascular diseases induced 
by chemotherapy) are neglected [87, 88]. As a consequence, the total effect of the exposing 
factors may be underestimated. 
Furthermore, the accuracy of analyses using disease-specific mortality depends on the 
correct adjudication of the cause of death (accuracy of death certificates) [87] which has 
been shown to be often unreliable and may introduce bias [88-90]. The clinical 
determination of the cause of death is a complex procedure that is susceptible to several 
sources of error [89]. All-cause mortality might, therefore, be a more reliable endpoint in 
scientific analyses [87]. 
Altogether, all-cause mortality is a hard and distinct endpoint [87] and it is likely to be the 
most relevant endpoint for cancer patients themselves. The cause of death might be 
important for the underlying pathology of death but for the patient it is more important 
whether to survive a period of time or not. 
 
5.3.2 Exposure and covariate assessment 
Physical activity 
Although structured and validated questionnaires for the assessment of physical activity are 
widely established in epidemiological research [91, 92], self-reported physical activity is 
prone to recall and misclassification bias [93, 94]. It might, therefore, not be an entirely 
accurate and reliable measure for the amount and intensity of activities and, especially, for 
unstructured forms of activity (e.g., gardening and housework activities) [93, 95]. 
Alternatively, technical assessment tools, including accelerometry and pedometers, provide 
measurement methods that avoid these types of bias by objectively and technically 
measuring the duration and intensity of activities [96]. Thus, a combination of self-reported 
and objectively measured data might supply more precise and reliable information on 
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physical activity for analyses in research studies as compared to questionnaire-based 
assessment tools alone. 
 
Disease stage 
CRC can be divided into the following stages of disease: localized disease restricted to the 
bowel wall (stage I), regional disease spread through the bowel wall and to local organs 
(stage II) or spread to lymph nodes (stage III), and distant metastatic disease (stage IV) 
[37]. Disease prognosis is highly dependent on cancer stage. Stage I CRC has a 5-year 
survival rate of 90%, stage II and III diseases have a 5-year survival of 70%, and stage IV 
disease has a 5-year survival of 10% [37]. 
Unfortunately, in this cohort, data on cancer stage were not available. Therefore, the 
potential heterogeneity by disease stage in this sample could not have been considered as 
confounder in the survival analyses. However, because of the long survival time (median, 
6 years) from CRC diagnosis until assessment of the exposure variables (diet, physical 
activity, HRQOL), the study participants were defined as ‘long-term’ cancer survivors and it 
is likely that most of the participants had a lower disease stage and a better general 
prognosis enabling them to survive until exposure assessment, which was essential for 
inclusion in the analyses. This argues for a rather homogenous study population in terms 
of cancer stage. Moreover, the analyses were adjusted for the occurrence of metastases or 
other types of cancer as well as for the type of adjuvant or neoadjuvant therapies which are 
factors that are associated with cancer staging and the severity of the disease [33, 37, 97, 
98]. In addition, sensitivity analyses were conducted excluding I) individuals who reported 
a diagnosis of metastases or II) individuals who died within the first 12 months after 
exposure assessment. 
 
Comorbidities 
Comorbidities (coexisting diseases) are associated with poorer survival in cancer survivors, 
though they are not related to more advanced cancer stage or differences in tumor biology 
[99, 100]. Comorbidities are common in CRC survivors, probably because known risk 
factors for CRC (e.g., smoking, obesity, physical inactivity) are also risk factors for a range 
of other chronic disease conditions, such as cardiovascular disease [99, 100]. Especially in 
cancer patients with a generally good survival prognosis, the effect of comorbid diseases 
on mortality is relevant [99]. The data of the CRC survivor cohort, underlying this doctoral 
thesis, did not include comprehensive information on existing comorbidities. Therefore, 
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these potential confounders could not be considered in the multivariate analyses examining 
the association of lifestyle factors and HRQOL with survival in CRC survivors. Furthermore, 
the role of comorbidities as possible correlates of HRQOL could not be investigated, even 
though previous studies found evidence that HRQOL is affected by certain comorbidities 
[13, 18, 101]. 
 
 
5.4 Future research 
To date, several studies provided evidence for significant associations of certain dietary 
factors and physical activity levels after diagnosis with CRC survival. However, the majority 
of research findings still need to be replicated in further studies with large sample sizes and 
comprehensive and validated exposure, covariate, and outcome assessment. More studies 
are warranted to examine lifestyle factors, including diet, physical activity, and sedentary 
behavior, as well as HRQOL among populations of long-term CRC survivors. In general, 
research on cancer survivorship issues should be further extended and encouraged in the 
future [102]. Examining the prevalence and burden of long-term and late effects of cancer 
disease and treatment is of high significance. This might be realizable by the expansion of 
national cancer registries with valid and complete data and a routine assessment of PRO 
data in these registries [103]. Generally, HRQOL studies with high methodological (e.g., 
prospective design) and reporting quality are warranted [102]. 
With respect to future research questions related to nutritional epidemiology in CRC 
survivors, a special focus should be on dietary pattern analyses to incorporate synergistic 
and antagonistic interactions of different nutrients and foods and to better depict the normal 
mixed diet [104, 105]. Regarding physical activity assessment, future studies examining 
type and intensity of physical activity with a combination of objective (e.g., accelerometry) 
and self-reported measures are needed. A longitudinal study on physical activity, fitness, 
and nutrition and its effect on quality of life, cancer recurrence, and survival in CRC 
survivors, using questionnaires, fitness tests, and accelerometry for physical activity 
assessment, is currently ongoing [106]. Additionally, more studies on the impact of different 
activity types on CRC survival are required to provide evidence for the development of 
specific activity recommendations. Future studies may also investigate how to introduce 
interventions to promote lifestyle factors in daily practice [102]. Another important aspect is 
the assessment of determinants of adherence to lifestyle recommendations in CRC 
survivors in order to address individual needs and to achieve sustainable lifestyle 
improvement in CRC survivors [77]. 
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The majority of currently conducted studies, including the analyses of the present thesis, 
were observational and, thus, limited in their ability to evaluate causality. Hence, the current 
evidence calls for pilot intervention programs. Perspectively, more interventional studies like 
the current Norwegian randomized controlled food-based diet intervention, called the 
‘Norwegian Dietary Guidelines and Colorectal Cancer Survival study’ [107], are needed to 
examine the effect of specific dietary factors on cancer outcome. Concerning physical 
activity interventions, a randomized controlled intervention program was recently started 
with the objective of examining the impact of a three-year physical activity program, 
beginning two to six months after completion of adjuvant therapy, on survival in CRC 
patients [108, 109]. Greater evidence on the utility of physical activity interventions in CRC 
survivors is expected from this trial. As well for HRQOL research in CRC survivors, more 
randomized controlled trials are needed to clarify whether modification of clinical and 
lifestyle characteristics ultimately improve patient outcomes, including HRQOL and survival. 
 
 
5.5 Conclusion 
As CRC diagnosis, treatment, and survival rates are improving, the issues and needs of 
long-term CRC survivors warrant special attention. To improve well-being and survival of 
these cancer survivors, lifestyle factors following diagnosis, like diet and physical activity, 
play an important role because cancer survivors are potentially able to actively modify these 
factors in their daily routine. In addition to prolongation of life, HRQOL is of huge importance 
for cancer survivors. Therefore, the identification and characterization of potential 
determinants of HRQOL are matters of increased research and public health interest. This 
doctoral thesis contributes to the current knowledge by revealing associations between 
higher adherence to a Mediterranean and to a healthy Nordic diet, respectively, with 
reduced all-cause mortality in CRC long-term survivors. Furthermore, the evidence 
regarding a significant relation between higher physical activity after diagnosis and 
improved survival was strengthened suggesting that particular types of activity (sports, 
walking, gardening) are primarily associated with mortality. Additionally, more time of 
physical inactivity was independently associated with a worse prognosis. The HRQOL 
status seemed to be relatively high in the long term in CRC survivors with several 
sociodemographic and clinical characteristics emerging as correlates of HRQOL after 
diagnosis. Nearly all domains of HRQOL were found to be associated with all-cause 
mortality in the sense that a higher HRQOL or better functioning was related to better 
survival whereas more symptoms were related to worse survival. 
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Further research is warranted to expand the evidence on dietary factors, physical activity, 
and HRQOL after CRC diagnosis in relation to overall survival in interventional studies or 
large prospective cohort studies. Nevertheless, the current evidence underscores the 
reasonableness of targeted lifestyle recommendations, interventions, and educational 
programs as well as psychological and psychosocial support for CRC long-term survivors. 
Therefore, dedicated survivorship care programs and screening modules are needed to be 
established in clinical routine and trained health professionals’ work. 
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6 Summary 
Colorectal cancer (CRC) is one of the most common malignancies worldwide. Due to earlier 
diagnoses and more effective treatment strategies, the number of individuals surviving CRC 
is steadily growing. CRC survivors are highly interested in specific lifestyle 
recommendations to prevent disease recurrence and improve survival. Besides 
prolongation of life, health-related quality of life (HRQOL) of CRC survivors is a rising public 
health issue. This thesis evaluated the associations of defined dietary patterns, physical 
activity, and HRQOL, obtained on average 6 years after diagnosis, with mortality in CRC 
long-term survivors. In addition, the HRQOL status and correlates of HRQOL in long-term 
survivors of CRC were determined. 
Specifically, within a prospective cohort study of initially recruited 2733 CRC survivors from 
Northern Germany, the associations of adherence to two a priori-defined dietary patterns, 
the Mediterranean diet and the healthy Nordic diet, with all-cause mortality were examined 
using Cox regression models. Furthermore, total physical activity, different types of physical 
activity, sleep duration at night and at day, and television (TV) watching hours were related 
to survival. In addition, the HRQOL status of long-term CRC survivors was determined and 
sociodemographic and clinical correlates of HRQOL in these individuals were identified with 
cross-sectional logistic regression analyses. Moreover, Cox regression analyses were 
performed to investigate the association between HRQOL and mortality. 
A higher adherence to the Mediterranean and to the healthy Nordic dietary pattern was 
associated with reduced all-cause mortality, respectively. A higher amount of total physical 
activity, and specifically of sports, walking, and gardening activities was related to improved 
overall survival. More hours of sleep during the day and more hours of watching TV were 
associated with decreased survival. The HRQOL status of CRC survivors was relatively 
high. Sex, age, education, tumor location, metastases, other cancers, type of therapy, and 
a current stoma were statistically significant correlates of overall HRQOL and of different 
HRQOL domains. Higher HRQOL and better functioning was associated with lower all-
cause mortality while more symptoms were associated with higher all-cause mortality. 
Based on the existing evidence, it is reasonable to encourage CRC survivors to adhere to 
a healthy diet and to engage in regular physical activity. Future studies investigating lifestyle 
factors in relation to health outcomes in long-term (>5 years) survivors of CRC are 
warranted to further strengthen the evidence in order to develop specific lifestyle 
recommendations for long-term cancer survivors. The evaluation of HRQOL in CRC long-
term survivors may enable the implementation of more targeted survivorship care programs.     
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7 Zusammenfassung 
Das Kolorektale Karzinom (KRK) ist eine der häufigsten Krebserkrankungen weltweit. 
Aufgrund früherer Diagnosestellungen und effektiverer Therapieansätze steigt die Anzahl 
der KRK-Überlebenden kontinuierlich an. KRK-Überlebende haben ein großes Interesse an 
spezifischen Lebensstilempfehlungen, um ein erneutes Auftreten der Krebserkrankung zu 
verhindern und ihr Überleben zu verlängern. Darüber hinaus wird neben der 
Lebenszeitverlängerung auch die Lebensqualität von KRK-Überlebenden zu einem 
zunehmend relevanten Public Health-Thema. Die vorliegende Arbeit untersuchte die 
Assoziationen von definierten Ernährungsmustern, der körperlichen Aktivität und der 
Lebensqualität (je durchschnittlich 6 Jahre nach der Krebsdiagnose erhoben) mit der 
Gesamtmortalität von Langzeit-KRK-Überlebenden. Zudem wurden der 
Lebensqualitätsstatus und Korrelate der Lebensqualität von Langzeit-KRK-Überlebenden 
bestimmt. 
Im Rahmen einer prospektiven Kohortenstudie mit anfänglich 2733 rekrutierten KRK-
Überlebenden aus Norddeutschland wurden die Assoziationen zweier a priori-definierter 
Ernährungsmuster, der Mediterranen Ernährung und der gesunden nordischen Ernährung, 
mit der Gesamtmortalität mithilfe von Cox-Regressionen untersucht. Außerdem wurde die 
postdiagnostische körperliche Gesamtaktivität, verschiedene Arten der körperlichen 
Aktivität, die Schlafenszeit während des Tages und in der Nacht und die Zeit, die vor dem 
Fernseher verbracht wurde, im Zusammenhang mit der Gesamtmortalität analysiert. 
Darüber hinaus wurde der Lebensqualitätsstatus der Langzeit-KRK-Überlebenden ermittelt 
und soziodemographische und klinische Korrelate der Lebensqualität im 
Querschnittsdesign mithilfe von logistischen Regressionsanalysen identifiziert. Cox-
Regressionsanalysen wurden eingesetzt, um die Assoziation zwischen der Lebensqualität 
und der Gesamtmortalität zu untersuchen. 
Eine Ernährung, die sich stärker an der Mediterranen oder an der gesunden nordischen 
Ernährung orientierte, war mit einer geringeren Gesamtmortalität assoziiert. Ein höherer 
Umfang an körperlicher Gesamtaktivität und vor allem an Sport, Spazierengehen und 
Gartenarbeit zeigte ebenfalls eine Assoziation mit geringerer Gesamtmortalität. Längere 
Schlafenszeit am Tag und höherer Fernsehkonsum waren hingegen mit höherer 
Gesamtmortalität assoziiert. Die Lebensqualität der Langzeit-KRK-Überlebenden zeigte 
sich als relativ hoch. Geschlecht, Alter, Bildung, Tumorlokalisation, Metastasen, andere 
Krebserkrankungen, Therapieart und Stoma-Anlage wurden als statistisch signifikante 
Korrelate der Gesamt-Lebensqualität und verschiedener Lebensqualitätsbereiche 
identifiziert. Höhere Lebensqualität und bessere Funktionalität waren mit geringerer 
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Gesamtmortalität assoziiert, während stärkere Symptomatik mit höherer Gesamtmortalität 
assoziiert war. 
Aufgrund der vorhandenen Evidenz ist es sinnvoll, KRK-Überlebende zu einer gesunden 
Ernährungsweise und regelmäßiger körperlicher Aktivität zu ermutigen. Zukünftige Studien 
sind notwendig, die Lebensstilfaktoren bei Langzeit-KRK-Überlebenden (>5 Jahre nach der 
Diagnose) in Zusammenhang mit dem Gesundheitszustand erforschen, um spezifische 
Lebensstilempfehlungen für Krebsüberlebende entwickeln zu können. Die Untersuchung 
der Lebensqualität von Langzeitkrebsüberlebenden könnte die Implementierung gezielter 
Gesundheitsprogramme für Krebsüberlebende ermöglichen. 
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Figure 1. Study design of the PopGen colorectal cancer survivor cohort. Modified from [1].  
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